Vladimir Tolmachev

The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors

Larkina, Maria; Varvashenya, Ruslan; Prach, Anastasia; Plotnikov, Evgenii et al.

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 1945-1959, 2026

• DOI for The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order

Papalanis, Eleftherios; Li, Ruonan; Oroujeni, Maryam; Zhang, Jie et al.

Part of International Journal of Biological Macromolecules, 2026

• DOI for Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
• Download full text (pdf) of Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order

Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Tolmachev, Vladimir; Herlina, Amelinda Janice; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A. et al.

Part of International Journal of Molecular Sciences, 2026

• DOI for Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
• Download full text (pdf) of Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2026

• DOI for Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging
• Download full text (pdf) of Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Tolmachev, Vladimir M.; Bezverkhniaia, Ekaterina; Papalanis, Eleftherios; Muhammad, Abdullah Mujahid Bin et al.

Part of ACS Pharmacology & Translational Science, p. 3509-3522, 2025

• DOI for Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
• Download full text (pdf) of Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors

Larkina, Maria; Varvashenya, Ruslan; Prach, Anastasia; Plotnikov, Evgenii et al.

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 1945-1959, 2026

• DOI for The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order

Papalanis, Eleftherios; Li, Ruonan; Oroujeni, Maryam; Zhang, Jie et al.

Part of International Journal of Biological Macromolecules, 2026

• DOI for Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
• Download full text (pdf) of Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order

Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Tolmachev, Vladimir; Herlina, Amelinda Janice; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A. et al.

Part of International Journal of Molecular Sciences, 2026

• DOI for Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
• Download full text (pdf) of Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2026

• DOI for Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging
• Download full text (pdf) of Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Tolmachev, Vladimir M.; Bezverkhniaia, Ekaterina; Papalanis, Eleftherios; Muhammad, Abdullah Mujahid Bin et al.

Part of ACS Pharmacology & Translational Science, p. 3509-3522, 2025

• DOI for Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
• Download full text (pdf) of Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Larkina, Mariia; Yanovich, Gleb; Hasnowo, Lutfi Aditya; Varvashenya, Ruslan et al.

Part of International Journal of Molecular Sciences, 2025

• DOI for Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.
• Download full text (pdf) of Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2025

• DOI for Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.
• Download full text (pdf) of Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics

Bezverkhniaia, Ekaterina; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Tolmachev, Vladimir M. et al.

Part of European Journal of Pharmaceutical Sciences, 2025

• DOI for Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics
• Download full text (pdf) of Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics

Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Orlova, Anna; Rybina, Anastasia; Medvedeva, Anna; Zelchan, Roman et al.

Part of Pharmaceutics, 2025

• DOI for Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
• Download full text (pdf) of Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Rosenström, Ulrika; Tolmachev, Vladimir M. et al.

Part of ACS Pharmacology & Translational Science, p. 3600-3612, 2025

• DOI for Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m
• Download full text (pdf) of Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m

The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8

Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Varvashenya, Ruslan et al.

Part of Pharmaceutics, 2025

• DOI for The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8
• Download full text (pdf) of The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo

Nilvebrant, Johan; Fernandez Moro, Carlos; Papalanis, Eleftherios; Ostad Novin, Masih et al.

Part of Translational Oncology, 2025

• DOI for An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo
• Download full text (pdf) of An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo

Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle Study

Oroujeni, Maryam; Westerlund, Kristina; Papalanis, Eleftherios; van Deventer, Alexander et al.

Part of Journal of Nuclear Medicine, p. 1105-1111, 2025

• DOI for Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle Study

RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study

Kanellopoulos, Panagiotis; Bitzios, Athanasios; Zelepukin, Ivan; Bezverkhniaia, Ekaterina et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2025

• DOI for RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study
• Download full text (pdf) of RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study

Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture

Tolmachev, Vladimir M.; Vorobyeva, Anzhelika; Rosly, Alia Hani Binti; Garousi, Javad et al.

Part of International Journal of Molecular Sciences, 2025

• DOI for Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
• Download full text (pdf) of Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture

Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study

Medvedeva, Anna; Chernov, Vladimir; Larkina, Maria; Rybina, Anastasiya et al.

Part of ACS Pharmacology & Translational Science, p. 736-747, 2025

• DOI for Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study
• Download full text (pdf) of Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study

Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

Tolmachev, Vladimir M.; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A.; Rosly, Alia Hani et al.

Part of ACS Pharmacology & Translational Science, p. 706-717, 2025

• DOI for Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules
• Download full text (pdf) of Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography

Kanellopoulos, Panagiotis; Lundmark, Fanny; Abouzayed, Ayman; Balestri, Lorenzo Jacopo Ilic et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2025

• DOI for Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography
• Download full text (pdf) of Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography

Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Kanellopoulos, Panagiotis; Yu, Quanyi; Abouzayed, Abouzayed; Bezverkhniaia, Ekaterina et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2025

• DOI for Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?
• Download full text (pdf) of Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

Liu, Yongsheng; Oroujeni, Maryam; Liao, Yunqi; Vorobyeva, Anzhelika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4038-4048, 2024

• DOI for Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
• Download full text (pdf) of Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains

Konshina, Anastasia G.; Bocharov, Eduard V.; Konovalova, Elena V.; Schulga, Alexey A. et al.

Part of International Journal of Molecular Sciences, 2024

• DOI for Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains
• Download full text (pdf) of Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains

Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation

Oroujeni, Maryam; Carlqvist, Matilda; Ryer, Eva; Orlova, Anna et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2024

• DOI for Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation
• Download full text (pdf) of Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation

Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.

Zhang, Jie; Bodenko, Vitalina; Larkina, Maria; Bezverkhniaia, Ekaterina et al.

Part of Journal of Controlled Release, p. 468-478, 2024

• DOI for Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.
• Download full text (pdf) of Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.

Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting

Westerlund, Kristina; Oroujeni, Maryam; Gestin, Maxime; Clinton, Jacob et al.

Part of ACS Pharmacology & Translational Science, p. 1595-1611, 2024

• DOI for Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
• Download full text (pdf) of Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting

Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [^99mTc]Tc-(HE)₃-G3

Bragina, O. D.; Tashireva, L. A.; Loos, D. M.; Vtorushin, S. V. et al.

Part of Acta Naturae, p. 22-29, 2024

• DOI for Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [^99mTc]Tc-(HE)₃-G3
• Download full text (pdf) of Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [^99mTc]Tc-(HE)₃-G3

Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery

Nagy, Abel; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Landmark, Fredrika et al.

Part of ACS Omega, p. 36122-36133, 2024

• DOI for Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery
• Download full text (pdf) of Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery

Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer

Zelchan, Roman; Chernov, Vladimir; Medvedeva, Anna; Rybina, Anastasia et al.

Part of Cancers, 2024

• DOI for Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
• Download full text (pdf) of Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

Obeid, Karim; Kanellopoulos, Panagiotis; Abouzayed, Ayman; Mattsson, Adam et al.

Part of Pharmaceutics, 2024

• DOI for GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics
• Download full text (pdf) of GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [^99mTc]Tc-ADAPT6

Bragina, Olga; Tashireva, Liubov; Loos, Dmitriy; Chernov, Vladimir et al.

Part of Pharmaceutics, 2024

• DOI for Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [^99mTc]Tc-ADAPT6
• Download full text (pdf) of Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [^99mTc]Tc-ADAPT6

Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with ¹⁷⁷Lu

Machulkin, Aleksei E.; Petrov, Stanislav A.; Bodenko, Vitalina; Larkina, Mariia S. et al.

Part of ACS Pharmacology & Translational Science, p. 1457-1473, 2024

• DOI for Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with ¹⁷⁷Lu

Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer

Kanellopoulos, Panagiotis; Bezverkhniaia, Ekaterina; Abouzayed, Ayman; Rosenström, Ulrika et al.

Part of ACS Omega, p. 18608-18616, 2024

• DOI for Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer
• Download full text (pdf) of Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer

Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

Deyev, Sergey M.; Oroujeni, Maryam; Garousi, Javad; Graeslund, Torbjoern et al.

Part of International Journal of Molecular Sciences, 2024

• DOI for Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
• Download full text (pdf) of Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Rosenström, Ulrika; Tolmachev, Vladimir et al.

Part of International Journal of Molecular Sciences, 2024

• DOI for Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
• Download full text (pdf) of Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Larkina, Maria; Varvashenya, Ruslan; Yuldasheva, Feruza; Plotnikov, Evgenii et al.

Part of Molecular Pharmaceutics, p. 1919-1932, 2024

• DOI for Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Kanellopoulos, Panagiotis; Mattsson, Adam; Abouzayed, Ayman; Obeid, Karim et al.

Part of EJNMMI Radiopharmacy and Chemistry, 2024

• DOI for Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
• Download full text (pdf) of Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125

Tolmachev, Vladimir; Bodenko, Vitalina; Orlova, Anna; Schulga, Alexey et al.

Part of Oncology Letters, 2023

• DOI for Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125
• Download full text (pdf) of Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125

Применение препарата [^99mTc]Tc-DARPinG3 в оценке распространенности опухолевого процесса у больной с метастатическим HER2-позитивным раком молочной железы (клиническое наблюдение): [The Use of the [^99mTc]Tc-DARPinG3 in Assessing Tumor Process in a Patient with Metastatic HER2-Positive Breast Cancer (Clinical Case Report)]

Bragina, O. D.; Chernov, V. I.; Deyev, S. M.; Rybina, A. N. et al.

Part of Voprosi onkologii, p. 917-922, 2023

• DOI for Применение препарата [^99mTc]Tc-DARPinG3 в оценке распространенности опухолевого процесса у больной с метастатическим HER2-позитивным раком молочной железы (клиническое наблюдение): [The Use of the [^99mTc]Tc-DARPinG3 in Assessing Tumor Process in a Patient with Metastatic HER2-Positive Breast Cancer (Clinical Case Report)]
• Download full text (pdf) of Применение препарата [^99mTc]Tc-DARPinG3 в оценке распространенности опухолевого процесса у больной с метастатическим HER2-позитивным раком молочной железы (клиническое наблюдение): [The Use of the [^99mTc]Tc-DARPinG3 in Assessing Tumor Process in a Patient with Metastatic HER2-Positive Breast Cancer (Clinical Case Report)]

Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Liu, Yongsheng; Xu, Tianqi; Vorobyeva, Anzhelika; Loftenius, Annika et al.

Part of Cancers, 2023

• DOI for Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
• Download full text (pdf) of Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs

Yin, Wen; Xu, Tianqi; Ding, Haozhong; Zhang, Jie et al.

Part of Journal of Controlled Release, p. 515-527, 2023

• DOI for Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs

Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity

Leitao, Charles Dahlsson; Borras, Anna Mestre; Xu, Tianqi; Oroujeni, Maryam et al.

Part of Journal of Controlled Release, p. 185-195, 2023

• DOI for Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Abouzayed, Ayman; Kanellopoulos, Panagiotis; Gorislav, Alisa; Tolmachev, Vladimir et al.

Part of Biomolecules, 2023

• DOI for Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
• Download full text (pdf) of Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

Oroujeni, Maryam; Bezverkhniaia, Ekaterina A.; Xu, Tianqi; Liu, Yongsheng et al.

Part of Nuclear Medicine and Biology, 2023

• DOI for Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
• Download full text (pdf) of Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

Lundmark, Fanny; Abouzayed, Ayman; Rinne, Sara S.; Timofeev, Vasiliy et al.

Part of Cancers, 2023

• DOI for Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
• Download full text (pdf) of Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer

Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Rybina, Anstasiya et al.

Part of Theranostics, p. 4858-4871, 2023

• DOI for Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer
• Download full text (pdf) of Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer

¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

Abouzayed, Ayman; Seitova, Kamila; Lundmark, Fanny; Bodenko, Vitalina et al.

Part of Frontiers in Oncology, 2023

• DOI for ¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
• Download full text (pdf) of ¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Abouzayed, Ayman; Larkina, Mariia et al.

Part of International Journal of Molecular Sciences, 2023

• DOI for Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
• Download full text (pdf) of Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

Alhuseinalkhudhur, Ali; Lindman, Henrik; Liss, Per; Sundin, Tora et al.

Part of Journal of Nuclear Medicine, p. 1364-1370, 2023

• DOI for Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
• Download full text (pdf) of Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

A direct comparison of the diagnostic efficacy of alternative scaffold- based radiopharmaceuticals [⁹⁹mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 in patients with HER2-positive breast cancer

Bragina, O. D.; Deyev, S. M.; Garbukov, E. Yu; Goldberg, V. E. et al.

Part of BYULLETEN SIBIRSKOY MEDITSINY, p. 6-13, 2023

• DOI for A direct comparison of the diagnostic efficacy of alternative scaffold- based radiopharmaceuticals [⁹⁹mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 in patients with HER2-positive breast cancer
• Download full text (pdf) of A direct comparison of the diagnostic efficacy of alternative scaffold- based radiopharmaceuticals [⁹⁹mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 in patients with HER2-positive breast cancer

Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

Hasnowo, Lutfi A.; Larkina, Maria S.; Plotnikov, Evgenii; Bodenko, Vitalina et al.

Part of International Journal of Molecular Sciences, 2023

• DOI for Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
• Download full text (pdf) of Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [Tc-99m]Tc-ADAPT6 and [Tc-99m]Tc-(HE)(3)-G3, for Imaging of HER2-Positive Breast Cancer

Bragina, Olga; Chernov, Vladimir; Schulga, Alexey; Konovalova, Elena et al.

Part of Cancers, 2023

• DOI for Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [Tc-99m]Tc-ADAPT6 and [Tc-99m]Tc-(HE)(3)-G3, for Imaging of HER2-Positive Breast Cancer
• Download full text (pdf) of Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [Tc-99m]Tc-ADAPT6 and [Tc-99m]Tc-(HE)(3)-G3, for Imaging of HER2-Positive Breast Cancer

The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

Abouzayed, Ayman; Borin, Jesper; Lundmark, Fanny; Rybina, Anastasiya et al.

Part of Diagnostics, 2023

• DOI for The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity
• Download full text (pdf) of The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

Chernov, Vladimir; Rybina, Anastasiya; Zelchan, Roman; Medvedeva, Anna et al.

Part of Cancers, 2023

• DOI for Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
• Download full text (pdf) of Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model

Xu, Tianqi; Schulga, Alexey; Konovalova, Elena; Rinne, Sara S. et al.

Part of International Journal of Molecular Sciences, 2023

• DOI for Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
• Download full text (pdf) of Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model

Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells

Xu, Tianqi; Liu, Yongsheng; Schulga, Alexey; Konovalova, Elena et al.

Part of Oncology Reports, 2022

• DOI for Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells
• Download full text (pdf) of Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071

Liu, Yongsheng; Vorobyeva, Anzhelika; Orlova, Anna; Konijnenberg, Mark W. et al.

Part of Pharmaceutics, 2022

• DOI for Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071
• Download full text (pdf) of Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071

Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis

Liu, Yongsheng; Gueler, Rezan; Liao, Yunqi; Vorobyeva, Anzhelika et al.

Part of Pharmaceutics, 2022

• DOI for Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis
• Download full text (pdf) of Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis

Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2

Xu, Tianqi; Zhang, Jie; Oroujeni, Maryam; Tretyakova, Maria S. et al.

Part of Pharmaceutics, 2022

• DOI for Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
• Download full text (pdf) of Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2

Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

Oroujeni, Maryam; Bezverkhniaia, Ekaterina A.; Xu, Tianqi; Liu, Yongsheng et al.

Part of Pharmaceutics, 2022

• DOI for Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
• Download full text (pdf) of Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

Phase I Clinical Trial Using [Tc-99m]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients

Chernov, Vladimir; Dudnikova, Ekaterina; Zelchan, Roman; Medvedeva, Anna et al.

Part of Pharmaceutics, 2022

• DOI for Phase I Clinical Trial Using [Tc-99m]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients
• Download full text (pdf) of Phase I Clinical Trial Using [Tc-99m]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients

Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

Garousi, Javad; Xu, Tianqi; Liu, Yongsheng; Vorontsova, Olga et al.

Part of Pharmaceutics, 2022

• DOI for Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
• Download full text (pdf) of Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development

Tolmachev, Vladimir; Vorobyeva, Anzhelika

Part of Cancers, 2022

• DOI for Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development
• Download full text (pdf) of Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development

Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT

Liu, Yongsheng; Yu, Shengze; Xu, Tianqi; Bodenko, Vitalina et al.

Part of Pharmaceutics, 2022

• DOI for Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
• Download full text (pdf) of Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT

Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using (99)mTc-DARPinG3

Bragina, O. D.; Tashireva, L. A.; Chernov, V. ; Deyev, S. M. et al.

Part of BYULLETEN SIBIRSKOY MEDITSINY, p. 6-12, 2022

• DOI for Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using (99)mTc-DARPinG3
• Download full text (pdf) of Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using (99)mTc-DARPinG3

Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins

Bragina, O. D.; Chernov, V. ; Deyev, S. M.; Tolmachev, Vladimir

Part of BYULLETEN SIBIRSKOY MEDITSINY, p. 132-139, 2022

• DOI for Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins
• Download full text (pdf) of Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins

Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy

Tolmachev, Vladimir; Bodenko, Vitalina; Oroujeni, Maryam; Deyev, Sergey et al.

Part of International Journal of Molecular Sciences, 2022

• DOI for Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
• Download full text (pdf) of Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy

Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with Tc-99m for Radionuclide Imaging of HER2 Expression in Cancer

Larkina, Mariia; Plotnikov, Evgenii; Bezverkhniaia, Ekaterina; Shabanova, Yulia et al.

Part of International Journal of Molecular Sciences, 2022

• DOI for Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with Tc-99m for Radionuclide Imaging of HER2 Expression in Cancer
• Download full text (pdf) of Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with Tc-99m for Radionuclide Imaging of HER2 Expression in Cancer

Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Oroujeni, Maryam; Tano, Hanna; Vorobyeva, Anzhelika; Liu, Yongsheng et al.

Part of Journal of Nuclear Medicine, p. 1046-1051, 2022

• DOI for Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer

Bragina, Olga; Chernov, Vladimir; Schulga, Alexey; Konovalova, Elena et al.

Part of Journal of Nuclear Medicine, p. 528-535, 2022

• DOI for Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain

Liu, Yongsheng; Vorobyeva, Anzhelika; Xu, Tianqi; Orlova, Anna et al.

Part of Pharmaceutics, 2021

• DOI for Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain
• Download full text (pdf) of Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain

A method of drug delivery to tumors based on rapidly biodegradable drug-loaded containers

Parakhonskiy, Bogdan; Shilyagina, Natalia Yu; Gusliakova, Olga; Volovetskiy, Artur B. et al.

Part of Applied Materials Today, 2021

• DOI for A method of drug delivery to tumors based on rapidly biodegradable drug-loaded containers

Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

Xu, Tianqi; Ding, Haozhong; Vorobyeva, Anzhelika; Oroujeni, Maryam et al.

Part of Cancers, 2021

• DOI for Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
• Download full text (pdf) of Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein

Garousi, Javad; Ding, Haozhong; von Witting, Emma; Xu, Tianqi et al.

Part of Pharmaceutics, 2021

• DOI for Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein
• Download full text (pdf) of Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein

Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle

Garousi, Javad; von Witting, Emma; Borin, Jesper; Vorobyeva, Anzhelika et al.

Part of Biomaterials, 2021

• DOI for Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle
• Download full text (pdf) of Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution

Ding, Haozhong; Xu, Tianqi; Zhang, Jie; Tolmachev, Vladimir et al.

Part of Pharmaceutics, 2021

• DOI for Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
• Download full text (pdf) of Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution

The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy

Yin, Wen; Xu, Tianqi; Altai, Mohamed; Oroujeni, Maryam et al.

Part of Pharmaceutics, 2021

• DOI for The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
• Download full text (pdf) of The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy

Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer

Abouzayed, Ayman; Rinne, Sara S.; Sabahnoo, Hamideh; Sörensen, Jens et al.

Part of Pharmaceutics, 2021

• DOI for Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer
• Download full text (pdf) of Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer

The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule

Oroujeni, Maryam; Xu, Tianqi; Gagnon, Katherine; Rinne, Sara S. et al.

Part of Pharmaceutics, 2021

• DOI for The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
• Download full text (pdf) of The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule

Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting

Tano, Hanna; Oroujeni, Maryam; Vorobyeva, Anzhelika; Westerlund, Kristina et al.

Part of Cancers, 2021

• DOI for Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
• Download full text (pdf) of Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model

Xu, Tianqi; Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena et al.

Part of Cancers, 2021

• DOI for Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
• Download full text (pdf) of Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

Deyev, Sergey M.; Xu, Tianqi; Liu, Yongsheng; Schulga, Alexey et al.

Part of Cancers, 2021

• DOI for Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
• Download full text (pdf) of Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

Oroujeni, Maryam; Rinne, Sara S.; Vorobyeva, Anzhelika; Loftenius, Annika et al.

Part of International Journal of Molecular Sciences, 2021

• DOI for Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
• Download full text (pdf) of Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26

Rinne, Sara S.; Abouzayed, Ayman; Gagnon, Katherine; Tolmachev, Vladimir et al.

Part of Scientific Reports, 2021

• DOI for Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
• Download full text (pdf) of Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26

HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers

Rinne, Sara S.; Dahlsson Leitao, Charles; Abouzayed, Ayman; Vorobyeva, Anzhelika et al.

Part of Cancers, p. 4791-4791, 2021

• DOI for HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
• Download full text (pdf) of HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers

Phase I study of ^99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer

Bragina, Olga; von Witting, Emma; Garousi, Javad; Zelchan, Roman et al.

Part of Journal of Nuclear Medicine, p. 493-499, 2021

• DOI for Phase I study of ^99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer

Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

Bragina, O. D.; Chernov, V. I.; Garbukov, E. Yu; Doroshenko, A. V. et al.

Part of Bûlleten' sibirskoj mediciny, p. 23-30, 2021

• DOI for Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
• Download full text 1 (pdf) of Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
• Download full text 2 (pdf) of Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

In vitro and in vivo evaluation of the radiochemical compound based on 99mtechnetium labelled DARPin9_29 for molecular visualization of malignancies overexpressing Her2/neu

Bragina, O. D.; Vorobyeva, Anzhelika; Tolmachev, Vladimir M.; Orlova, Anna et al.

Part of Medical Radiology and Radiation Safety, p. 37-41, 2020

• DOI for In vitro and in vivo evaluation of the radiochemical compound based on 99mtechnetium labelled DARPin9_29 for molecular visualization of malignancies overexpressing Her2/neu

Возможности радионуклидной визуализации HER2/neu-позитивного рака молочной железы с использованием радиофармпрепарата на основе рекомбинантных адресных молекул DARPin9_29: [Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29]

Bragina, Olga D.; Chernov, Vladimir I.; Medvedeva, Anna A.; Zelchan, Roman V. et al.

Part of Sibirskij Nauchnyj Medicinskij Zhurnal, p. 35-43, 2020

• DOI for Возможности радионуклидной визуализации HER2/neu-позитивного рака молочной железы с использованием радиофармпрепарата на основе рекомбинантных адресных молекул DARPin9_29: [Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29]

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Rinne, Sara S.; Xu, Tianqi; Leitao, Charles Dahlsson; Stahl, Stefan et al.

Part of International Journal of Molecular Sciences, 2020

• DOI for Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
• Download full text (pdf) of Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

Ding, Haozhong; Altai, Mohamed; Yin, Wen; Lindbo, Sarah et al.

Part of Pharmaceutics, 2020

• DOI for HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution
• Download full text (pdf) of HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

Abouzayed, Ayman; Tano, Hanna; Nagy, Abel; Rinne, Sara S. et al.

Part of Pharmaceutics, 2020

• DOI for Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
• Download full text (pdf) of Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

Lundmark, Fanny; Abouzayed, Ayman; Mitran, Bogdan; Rinne, Sara S. et al.

Part of Pharmaceutics, 2020

• DOI for Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
• Download full text (pdf) of Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Leitao, Charles Dahlsson; Rinne, Sara S.; Altai, Mohamed; Vorontsova, Olga et al.

Part of Pharmaceutics, 2020

• DOI for Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.
• Download full text (pdf) of Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

Alhuseinalkhudhur, Ali; Lubberink, Mark; Lindman, Henrik; Tolmachev, Vladimir et al.

Part of EJNMMI Research, 2020

• DOI for Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
• Download full text (pdf) of Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

Baun, Christina; Mitran, Bogdan; Rinne, Sara S.; Dam, Johan H. et al.

Part of Molecules, 2020

• DOI for Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
• Download full text (pdf) of Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

Vorobyeva, Anzhelika; Bezverkhniaia, Ekaterina; Konovalova, Elena; Schulga, Alexey et al.

Part of Molecules, 2020

• DOI for Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
• Download full text (pdf) of Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Myrhammar, Anders; Vorobyeva, Anzhelika; Westerlund, Kristina; Yoneoka, Shuichiro et al.

Part of Scientific Reports, 2020

• DOI for Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting
• Download full text (pdf) of Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Garousi, Javad; Orlova, Anna; Frejd, Fredrik Y.; Tolmachev, Vladimir

Part of EJNMMI Radiopharmacy and Chemistry, 2020

• DOI for Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Vorobyeva, Anzhelika; Konovalova, Elena; Xu, Tianqi; Schulga, Alexey et al.

Part of International Journal of Molecular Sciences, 2020

• DOI for Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
• Download full text (pdf) of Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

Rinne, Sara S.; Leitao, Charles Dahlsson; Saleh-nihad, Zahra; Mitran, Bogdan et al.

Part of International Journal of Molecular Sciences, 2020

• DOI for Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
• Download full text (pdf) of Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

Efficient Synthesis of omega-[F-18]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography

Larkina, Mariia; Ozerskaya, Anastasia; Podrezova, Ekaterina; Belousov, Mikhail et al.

Part of European Journal of Organic Chemistry, p. 6375-6381, 2020

• DOI for Efficient Synthesis of omega-[F-18]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography

Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1

Deyev, Sergey M.; Vorobyeva, Anzhelika; Schulga, Alexey; Abouzayed, Ayman et al.

Part of International Journal of Biological Macromolecules, p. 216-225, 2020

• DOI for Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1
• Download full text (pdf) of Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1

Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates

Ding, Haozhong; Altai, Mohamed; Rinne, Sara S.; Vorobyeva, Anzhelika et al.

Part of Cancers, 2019

• DOI for Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates
• Download full text (pdf) of Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers

Dahlsson Leitao, Charles; Rinne, Sara S.; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Part of International Journal of Molecular Sciences, 2019

• DOI for Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers
• Download full text (pdf) of Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Rinne, Sara S.; Leitao, Charles Dahlsson; Mitran, Bogdan; Bass, Tarek Z. et al.

Part of Scientific Reports, 2019

• DOI for Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
• Download full text (pdf) of Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Potent and specific fusion toxins consisting of a HER2-binding, ABD-derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A

Liu, Hao; Lindbo, Sarah; Ding, Haozhong; Altai, Mohamed et al.

Part of International Journal of Oncology, p. 309-319, 2019

• DOI for Potent and specific fusion toxins consisting of a HER2-binding, ABD-derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

Abouzayed, Ayman; Yim, Cheng-Bin; Mitran, Bogdan; Rinne, Sara S. et al.

Part of Pharmaceutics, 2019

• DOI for Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
• Download full text (pdf) of Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

Oroujeni, Maryam; Abouzayed, Ayman; Lundmark, Fanny; Mitran, Bogdan et al.

Part of Pharmaceutics, 2019

• DOI for Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart
• Download full text (pdf) of Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

Rosestedt, Maria; Andersson, Ken G.; Rinne, Sara S.; Leitao, Charles Dahlsson et al.

Part of Scientific Reports, 2019

• DOI for Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
• Download full text (pdf) of Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena; Guler, Rezan et al.

Part of Scientific Reports, 2019

• DOI for Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3
• Download full text (pdf) of Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts

Garousi, Javad; Huizing, Fokko J.; Vorobyeva, Anzhelika; Mitran, Bogdan et al.

Part of Scientific Reports, 2019

• DOI for Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts
• Download full text (pdf) of Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts

Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

Rinne, Sara S.; Leitao, Charles Dahlsson; Gentry, Joshua; Mitran, Bogdan et al.

Part of Scientific Reports, 2019

• DOI for Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules
• Download full text (pdf) of Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models

Huizing, Fokko J.; Garousi, Javad; Lok, Jasper; Franssen, Gerben et al.

Part of Scientific Reports, 2019

• DOI for CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
• Download full text (pdf) of CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Mitran, Bogdan; Thisgaard, Helge; Rinne, Sara S.; Dam, Johan Hygum et al.

Part of Scientific Reports, 2019

• DOI for Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
• Download full text (pdf) of Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

Vorobyeva, Anzhelika; Schulga, Alexey; Rinne, Sara S.; Günther, Tyran et al.

Part of International Journal of Molecular Sciences, 2019

• DOI for Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
• Download full text (pdf) of Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2

Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena; Güler, Rezan et al.

Part of International Journal of Oncology, p. 1209-1220, 2019

• DOI for Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
• Download full text (pdf) of Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2

Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer

Mitran, Bogdan; Varasteh, Zohreh; Abouzayed, Ayman; Rinne, Sara S. et al.

Part of Cancers, 2019

• DOI for Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
• Download full text (pdf) of Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

Mitran, Bogdan; Rinne, Sara S.; Konijnenberg, Mark W.; Maina, Theodosia et al.

Part of International Journal of Cancer, p. 3347-3358, 2019

• DOI for Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
• Download full text (pdf) of Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6

von Witting, Emma; Garousi, Javad; Lindbo, Sarah; Vorobyeva, Anzhelika et al.

Part of European journal of pharmaceutics and biopharmaceutics, p. 109-120, 2019

• DOI for Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6
• Download full text (pdf) of Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6

Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting

Westerlund, Kristina; Vorobyeva, Anzhelika; Mitran, Bogdan; Orlova, Anna et al.

Part of Biomaterials, p. 73-85, 2019

• DOI for Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting
• Download full text (pdf) of Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting

Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties

Deyev, Sergey; Vorobyeva, Anzhelika; Schulga, Alexey; Proshkina, Galina et al.

Part of Molecular Pharmaceutics, p. 995-1008, 2019

• DOI for Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties

Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

Garousi, Javad; Lindbo, Sarah; Borin, Jesper; von Witting, Emma et al.

Part of European journal of pharmaceutics and biopharmaceutics, p. 37-48, 2019

• DOI for Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours
• Download full text (pdf) of Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z(EGFR:2377)

Mitran, Bogdan; Andersson, Ken Gosta; Lindström, Elin; Garousi, Javad et al.

Part of Oncology Reports, p. 534-542, 2019

• DOI for Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z(EGFR:2377)

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

Vorobyeva, Anzhelika; Bragina, Olga; Altai, Mohamed; Mitran, Bogdan et al.

Part of Contrast Media & Molecular Imaging, p. 1-11, 2018

• DOI for Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
• Download full text (pdf) of Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

Orlova, Anna; Bass, Tarek Z.; Rinne, Sara S.; Leitao, Charles Dahlsson et al.

Part of Molecular Pharmaceutics, p. 3394-3403, 2018

• DOI for Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs

Altai, Mohamed; Leitao, Charles Dahlsson; Rinne, Sara S.; Vorobyeva, Anzhelika et al.

Part of Cells, 2018

• DOI for Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
• Download full text (pdf) of Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs

Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors

Altai, Mohamed; Liu, Hao; Ding, Haozhong; Mitran, Bogdan et al.

Part of Journal of Controlled Release, p. 84-95, 2018

• DOI for Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors

Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse

Nordling, Sofia; Brännström, Johan; Carlsson, Fredrik; Lu, Bo et al.

Part of Scientific Reports, 2018

• DOI for Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse
• Download full text (pdf) of Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse

Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

Mitran, Bogdan; Güler, Rezan; Roche, Francis P.; Lindström, Elin et al.

Part of Theranostics, p. 4462-4476, 2018

• DOI for Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
• Download full text (pdf) of Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe

Honarvar, Hadis; Calce, Enrica; Doti, Nunzianna; Langella, Emma et al.

Part of Scientific Reports, 2018

• DOI for Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
• Download full text (pdf) of Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe

Molecular design of radiocopper-labelled Affibody molecules

Tolmachev, Vladimir; Grönroos, Tove J; Yim, Cheng-Bin; Garousi, Javad et al.

Part of Scientific Reports, 2018

• DOI for Molecular design of radiocopper-labelled Affibody molecules
• Download full text (pdf) of Molecular design of radiocopper-labelled Affibody molecules

Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

Vorobyeva, Anzhelika; Westerlund, Kristina; Mitran, Bogdan; Altai, Mohamed et al.

Part of Scientific Reports, 2018

• DOI for Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy
• Download full text (pdf) of Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

PP15 89Zr-Siderophore-Affibody conjugates for imaging EGFR expression

Summer, D; Garousi, Javad; Oroujeni, Maryam; Mitran, Bogdan et al.

Part of EJNMMI Research, 2018

• DOI for PP15 89Zr-Siderophore-Affibody conjugates for imaging EGFR expression

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules

Oroujeni, Maryam; Andersson, Ken G.; Steinhardt, Xenia; Altai, Mohamed et al.

Part of Amino Acids, p. 981-994, 2018

• DOI for Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules
• Download full text (pdf) of Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules

Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

Oroujeni, Maryam; Garousi, Javad; Andersson, Ken G.; Lofblom, John et al.

Part of CELLS, 2018

• DOI for Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
• Download full text (pdf) of Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

Summer, Dominik; Garousi, Javad; Oroujeni, Maryam; Mitran, Bogdan et al.

Part of Molecular Pharmaceutics, p. 175-185, 2018

• DOI for Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
• Download full text (pdf) of Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

Westerlund, Kristina; Altai, Mohamed; Mitran, Bogdan; Konijnenberg, Mark et al.

Part of Journal of Nuclear Medicine, p. 1092-1098, 2018

• DOI for Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

Selection of the most optimal ADAPT6-based probe for imaging of HER2 using PET and SPECT

Garousi, Javad; Lindbo, S.; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Kinetic Analysis of the HER2-binding ABY-025 Affibody Using Dynamic PET in Patients with Metastatic Breast Cancer

Alhuseinalkhudhur, Ali; Lubberink, Mark; Velikyan, Irina; Tolmachev, Vladimir et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with ¹¹¹In and ⁶⁸Ga

Lindbo, Sarah; Garousi, Javad; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Part of Molecular Pharmaceutics, p. 2674-2683, 2018

• DOI for Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with ¹¹¹In and ⁶⁸Ga

Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Molecular Imaging of HER2 Expression in Cancer Using SPECT

Vorobyeva, Anzhelika; Bragina, O.; Altai, Mohamed; Mitran, Bogdan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Molecular Imaging of HER2 Expression in Cancer Using SPECT

Development of a PET Imaging Approach for Selection of Patients for Affibody-Based PNA-Mediated Pretargeted Radionuclide Therapy

Vorobyeva, Anzhelika; Westerlund, K.; Mitran, Bogdan; Altai, Mohamed et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Development of a PET Imaging Approach for Selection of Patients for Affibody-Based PNA-Mediated Pretargeted Radionuclide Therapy

Imaging contrast of HER3 expression using monomeric affibody-based imaging probe can be improved by co-injection of affibody trimer

Orlova, Anna; Rosestedt, Maria; Rinne, Sara S.; Mitran, Bogdan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Imaging contrast of HER3 expression using monomeric affibody-based imaging probe can be improved by co-injection of affibody trimer

Optimization of molecular design of Ga-68-labeled affibody molecule for PET imaging of HER3 expression

Rinne, Sara S.; Mitran, Bogdan; Vorobyeva, Anzhelika; Leitao, C. Dahlsson et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Optimization of molecular design of Ga-68-labeled affibody molecule for PET imaging of HER3 expression

Comparative evaluation of anti-EFGR affibody molecules labelled with gallium-68 and zirconium-89 using desferrioxamine B as a chelator

Oroujeni, Maryam; Garousi, Javad; Andersson, K.; Löfblom, J. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Comparative evaluation of anti-EFGR affibody molecules labelled with gallium-68 and zirconium-89 using desferrioxamine B as a chelator

GRPR-targeted radiotherapy using the Lu-177-labeled GRPR-antagonist DOTAGA-PEG(2)-RM26

Mitran, Bogdan; Rinne, Sara S.; Azamy, F.; Vorobyeva, Anzhelika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Selection of optimal macrocyclic chelator for high contrast PET imaging of gastrin releasing peptide receptor using cobalt-labeled bombesin antagonist RM26

Mitran, Bogdan; Thisgaard, H.; Rinne, Sara S.; Rosenström, Ulrika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Same-day imaging using small proteins: Clinical experience and translational prospects in oncology.

Krasniqi, Ahmet; D'Huyvetter, Matthias; Devoogdt, Nick; Frejd, Fredrik Y. et al.

Part of Journal of Nuclear Medicine, p. 885-891, 2018

• DOI for Same-day imaging using small proteins: Clinical experience and translational prospects in oncology.

Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label

Lindbo, Sarah; Garousi, Javad; Mitran, Bogdan; Buijs, Jos et al.

Part of Journal of Nuclear Medicine, p. 93-99, 2018

• DOI for Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label

Pretargeted Imaging and Therapy

Altai, Mohamed; Membreno, Rosemery; Cook, Brendon; Tolmachev, Vladimir et al.

Part of Journal of Nuclear Medicine, p. 1553-1559, 2017

• DOI for Pretargeted Imaging and Therapy

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

Garousi, Javad; Lindbo, Sarah; Mitran, Bogdan; Buijs, Jos et al.

Part of Scientific Reports, 2017

• DOI for Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
• Download full text (pdf) of Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

Garousi, Javad; Andersson, Ken G.; Dam, Johan H.; Olsen, Birgitte B. et al.

Part of Scientific Reports, 2017

• DOI for The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
• Download full text (pdf) of The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct

Bass, Tarek Z.; Rosestedt, Maria; Mitran, Bogdan; Frejd, Fredrik Y. et al.

Part of Scientific Reports, 2017

• DOI for In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct
• Download full text (pdf) of In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct

Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.

Sandberg, Dan T; Tolmachev, Vladimir; Velikyan, Irina; Olofsson, Helena et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1337-1346, 2017

• DOI for Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
• Download full text (pdf) of Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.

Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression

Rosestedt, Maria; Andersson, Ken G; Mitran, Bogdan; Rinne, Sara S. et al.

Part of International Journal of Oncology, p. 1765-1774, 2017

• DOI for Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
• Download full text (pdf) of Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression

High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26

Mitran, Bogdan; Thisgaard, Helge; Rosenström, Ulrika; Dam, Johan Hygum et al.

Part of Contrast Media & Molecular Imaging, 2017

• DOI for High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26
• Download full text (pdf) of High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26

Novel high affinity affibody for radionuclide imaging of VEGFR2 in glioma vasculature: proof-of-principle in murine model

Mitran, Bogdan; Guler, R.; Roche, Francis P.; Lindström, Elin et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Radiocobalt-labeled anti-HER1 affibody molecule DOTA-Z(EGFR:2377) for imaging of low HER1 expression in prostate cancer pre-clinical model

Mitran, Bogdan; Garousi, Javad; Rosestedt, Maria; Lindström, Elin et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Influence of composition of cysteine-containing peptide based chelators on biodistribution of Tc-99m-labelled anti-EGFR affibody molecules

Oroujeni, Maryam; Anderson, K. G.; Garousi, Javad; Altai, Mohamed et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

GRPR-Targeted Radiotherapy: Influence of Chelator on Labeling and Biodistribution of Four Lu-177-Labeled Analogues of the GRPR-Antagonist PEG2-RM26

Orlova, Anna; Mitran, Bogdan; Maina, T.; Nock, B. A. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Optimal molecular design of radiocopper-labelled affibody molecules

Tolmachev, Vladimir; Yim, C.; Garousi, Javad; Yue, Y. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Feasibility of Z Domain-Mediated Conjugation of PNA to Antibodies for Radionuclide Pretargeting

Vorobyeva, Anzhelika; Altai, Mohamed; Westerlund, K.; Al-Ramadan, Afkar et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Optimization of affibody molecule for imaging of HER3 expression: negatively charged metal-chelator complex increases imaging contrast

Rinne, Sara S.; Mitran, Bogdan; Leitao, C. Dahlsson; Ståhl, S. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Evaluation of the first (44)Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Honarvar, Hadis; Müller, Cristina; Cohrs, Susan; Haller, Stephanie et al.

Part of Nuclear Medicine and Biology, p. 15-21, 2017

• DOI for Evaluation of the first (44)Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA

Tolmachev, Vladimir; Yim, Cheng-Bin; Rajander, Johan; Perols, Anna et al.

Part of Contrast Media & Molecular Imaging, p. 1-12, 2017

• DOI for Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA
• Download full text (pdf) of Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA

Control of growth factor binding and release in bisphosphonate functionalized hydrogels guides rapid diff erentiation of precursor cells in vitro

Kootala, Sujit; Zhang, Yu; Ghalib, Sara; Tolmachev, Vladimir et al.

Part of Biomaterials Science, p. 250-254, 2016

• DOI for Control of growth factor binding and release in bisphosphonate functionalized hydrogels guides rapid diff erentiation of precursor cells in vitro

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT

Sörensen, Jens; Velikyan, Irina; Sandberg, Dan; Wennborg, Anders et al.

Part of Theranostics, p. 262-271, 2016

• DOI for Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT
• Download full text (pdf) of Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT

Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

Honarvar, Hadis; Westerlund, Kristina; Altai, Mohamed; Sandström, Mattias et al.

Part of Theranostics, p. 93-103, 2016

• DOI for Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors
• Download full text (pdf) of Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Li, Xiujuan; Padhan, Narendra; Sjöström, Elisabet O.; Roche, Francis P. et al.

Part of Nature Communications, 2016

• DOI for VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
• Download full text (pdf) of VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Comparative evaluation of Affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX

Garousi, Javad; Honarvar, Hadis; Andersson, Ken G.; Mitran, Bogdan et al.

Part of Molecular Pharmaceutics, p. 3676-3687, 2016

• DOI for Comparative evaluation of Affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX

Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Mitran, Bogdan; Varasteh, Zohreh; Selvaraju, Ram Kumar; Lindeberg, Gunnar et al.

Part of International journal of oncology, p. 2124-2134, 2016

• DOI for Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules

Westerlund, Kristina; Honarvar, Hadis; Norrström, Emily; Strand, Joanna et al.

Part of Molecular Pharmaceutics, p. 1668-1678, 2016

• DOI for Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator

Andersson, Ken G.; Oroujeni, Maryam; Garousi, Javad; Mitran, Bogdan et al.

Part of International journal of oncology, p. 2285-2293, 2016

• DOI for Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
• Download full text (pdf) of Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator

Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin

Altai, Mohamed; Liu, Hao; Orlova, Anna; Tolmachev, Vladimir et al.

Part of International Journal of Oncology, p. 1185-1194, 2016

• DOI for Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin

Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma

Haylock, Anna-Karin; Spiegelberg, Diana; Mortensen, Anja C.; Selvaraju, Ram K. et al.

Part of International journal of oncology, p. 461-470, 2016

• DOI for Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
• Download full text (pdf) of Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma

Feasibility of in vivo imaging of VEGFR2 expression using high affinity antagonistic biparatopic affibody construct Z(VEGFR2)-Bp(2)

Mitran, Bogdan; Guler, R.; Lindström, Eva; Fleetwood, F. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions

Chiotellis, Aristeidis; Sladojevich, Filippo; Mu, Linjing; Müller Herde, Adrienne et al.

Part of Chemical Communications, p. 6083-6086, 2016

• DOI for Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions

Feasibility of affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting

Altai, Mohamed; Perols, Anna; Tsourma, Maria; Mitran, Bogdan et al.

Part of Journal of Nuclear Medicine, p. 431-436, 2016

• DOI for Feasibility of affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting

Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins.

Lindbo, Sarah; Garousi, Javad; Åstrand, Mikael; Honarvar, Hadis et al.

Part of Bioconjugate chemistry, p. 716-726, 2016

• DOI for Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins.

Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6

Garousi, Javad; Lindbo, Sarah; Honarvar, Hadis; Velletta, Justin et al.

Part of Bioconjugate chemistry, p. 2678-2688, 2016

• DOI for Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6

Evaluation of Affibody Molecules for Radionuclide Imaging of Carbonic Abhydrase IX Expression In Vivo

Garousi, Javad; Honarvar, Hadis; Andersson, K.; Mitran, Bogdan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Imaging of EGFR Expression Using 99mTC-Labelled ZEGFR:2377 Affibody Molecule

Oroujeni, Maryam; Andersson, K.; Garousi, Javad; Mitran, Bogdan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Comparative evaluation of Lu-177-HP2 and In-111-HP2, secondary agents for affibody-based PNA-mediated radionuclide pretargeting

Altai, Mohamed; Westerlund, K.; Velletta, J.; Honarvar, Hadis et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Development and application of first Sc-44-labeled Affibody molecule

Honarvar, Hadis; Müller, C.; van der Meulen, N.; Cohrs, S. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

In vivo evaluation of pharmacokinetics, tumors targeting and therapeutic efficacy of a novel format of HER3-targeting affibody molecule with prolonged blood circulation

Orlova, Anna; Rosestedt, Maria; Mitran, Bogdan; Bass, T. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Improving of molecular design of a novel Affibody-fused HER2-recognising anticancer toxin using radionuclide-based techniques

Altai, Mohamed; Liu, H.; Orlova, Anna; Tolmachev, Vladimir et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Novel Chemoselective [F-18]-Radiolabeling of Thiol-Containing Biomolecules under Mild Aqueous Conditions

Chiotellis, A.; Sladojevich, F.; Mu, L.; Mueller-Herde, A. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Influence of the N-terminal amino acid sequence on imaging properties of In-111-labeled anti-HER2 scaffold protein ADAPT6

Garousi, Javad; Lindbo, S.; Honarvar, Hadis; Velletta, J. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Development and Evaluation of Radiocobalt-labelled Affibody Molecule for Next Day PET Imaging of HER3 Expression

Rosestedt, Maria; Mitran, Bogdan; Andersson, K. G.; Löfblom, J. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

Sandström, Mattias; Lindskog, Karolina; Velikyan, Irma; Wennborg, Anders et al.

Part of Journal of Nuclear Medicine, p. 867-871, 2016

• DOI for Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.

Garousi, Javad; Andersson, Ken G; Mitran, Bogdan; Pichl, Marie-Louise et al.

Part of International journal of oncology, p. 1325-1332, 2016

• DOI for PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.
• Download full text (pdf) of PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.

ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers

Garousi, Javad; Lindbo, Sarah; Nilvebrant, Johan; Åstrand, Mikael et al.

Part of Cancer Research, p. 4364-4371, 2015

• DOI for ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers

Affibody-mediated PET imaging of HER3 expression in malignant tumours

Rosestedt, Maria; Andersson, Ken G.; Mitran, Bogdan; Tolmachev, Vladimir et al.

Part of Scientific Reports, 2015

• DOI for Affibody-mediated PET imaging of HER3 expression in malignant tumours
• Download full text (pdf) of Affibody-mediated PET imaging of HER3 expression in malignant tumours

Development of radiocobalt-labeled GRPR antagonist NOTA-PEG2-RM26.

Mitran, Bogdan; Varasteh, Zohreh; Rosenström, Ulrika; Tolmachev, Vladimir et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

The use of radiocobalt as a label improves PET imaging of EGFR using DOTA-conjugated affibody molecules

Garousi, Javad; Anderson, K.; Dam, J. H.; Olsen, B. B. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Influence of chelators on targeting properties of In-111 and Ga-68 labeled GRPR antagonist

Orlova, Anna; Varasteh, Zohreh; Mitran, Bogdan; Rosestedt, Maria et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2015

Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

Mitran, Bogdan; Altai, Mohamed; Hofström, Camilla; Honarvar, Hadis et al.

Part of Amino Acids, p. 303-15, 2015

• DOI for Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
• Download full text (pdf) of Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 Affibody molecule

Honarvar, Hadis; Garousi, Javad; Gunneriusson, Elin; Höidén-Guthenberg, Ingmarie et al.

Part of International Journal of Oncology, p. 513-20, 2015

• DOI for Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 Affibody molecule
• Download full text (pdf) of Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 Affibody molecule

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Andersson, Ken G.; Rosestedt, Maria; Varasteh, Zohreh; Malm, Magdalena et al.

Part of Oncology Reports, p. 1042-1048, 2015

• DOI for Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors
• Download full text (pdf) of Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin Z(HER2:2891)-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain

Liu, Hao; Seijsing, Johan; Frejd, Fredrik Y.; Tolmachev, Vladimir et al.

Part of International Journal of Oncology, p. 601-609, 2015

• DOI for Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin Z(HER2:2891)-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain

The effect of macrocyclic chelators on the targeting properties of the ⁶⁸Ga-labeled gastrin releasing peptide receptor antagonist PEG₂-RM26

Varasteh, Zohreh; Mitran, Bogdan; Rosenström, Ulrika; Velikyan, Irina et al.

Part of Nuclear Medicine and Biology, p. 446-454, 2015

• DOI for The effect of macrocyclic chelators on the targeting properties of the ⁶⁸Ga-labeled gastrin releasing peptide receptor antagonist PEG₂-RM26

Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting

Westerlund, Kristina; Honarvar, Hadis; Tolmachev, Vladimir; Eriksson Karlström, Amelie

Part of Bioconjugate chemistry, p. 1724-1736, 2015

• DOI for Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting

Non-invasive determination of HER2-expression in metastatic breast cancer by using Ga-68-ABY025 PET/CT.

Lindman, Henrik; Wennborg, Anders; Velikyan, Irina; Feldwisch, Joachim et al.

Part of Journal of Clinical Oncology, 2015

Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

Strand, Joanna; Nordeman, Patrik; Honarvar, Hadis; Altai, Mohamed et al.

Part of ChemistryOpen, p. 174-182, 2015

• DOI for Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity
• Download full text (pdf) of Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

Affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting: proof-of-principle

Altai, Mohamed; Tsourma, M.; Mitran, Bogdan; Honarvar, Hadis et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Feasibility of Affibody molecule-based PNA-mediated pretargeting

Honarvar, Hadis; Westerlund, K.; Altai, Mohamed; Sandstrom, Mattias et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Influence of Histidine-Containing Tags on Biodistribution of Radiolabelled ADAPT-Based Imaging Probes

Lindbo, S.; Garousi, Javad; Astrand, M.; Honarvar, Hadis et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Good manufacturing practice compliant production of a Ga-68-labelled Affibody agent for breast cancer imaging: first-in-human

Velikyan, Irina; Wennborg, Anders; Feldwisch, Joachim; Orlova, Anna et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2015

Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga- Compared to 111In-Labeled Conjugates.

Honarvar, Hadis; Strand, Joanna; Perols, Anna; Orlova, Anna et al.

Part of Molecular Imaging, p. 1-12, 2014

• DOI for Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga- Compared to 111In-Labeled Conjugates.

The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin

Varasteh, Zohreh; Rosenström, Ulrika; Velikyan, Irina; Mitran, Bogdan et al.

Part of Molecules, p. 10455-10472, 2014

• DOI for The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin
• Download full text (pdf) of The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin

Measuring HER2-expression in metastatic breast cancer using 68Ga-ABY025 PET/CT

Sörensen, Jens; Velikyan, Irina; Wennborg, A.; Feldwisch, J. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

GMP compliant preparation of a (68)Gallium-labeled Affibody analogue for breast cancer patient examination: first-in-man

Velikyan, Irina; Wennborg, A.; Feldwisch, J.; Orlova, Anna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

111In-labeled NOTA-conjugated Affibody molecules for visualization of HER3 expression in malignant tumors

Andersson, K. G.; Varasteh, Zohreh; Rosestedt, Maria; Malm, M. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Development of ADAPT6 as a new scaffold protein for radionuclide molecular imaging

Garousi, Javad; Lindbo, S.; Orlova, Anna; Astrand, M. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Radiation dosimetry and tracer kinetic analysis of Ga-68-ABY025 Affibody in breast cancer patients

Lubberink, Mark; Lindskog, K.; Sandström, Mattias; Velikyan, Irina et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.

Tugues, Sònia; Roche, Francis; Noguer, Oriol; Orlova, Anna et al.

Part of PLOS ONE, 2014

• DOI for Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.
• Download full text (pdf) of Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.

Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

Tolmachev, Vladimir; Malmberg, Jennie; Estrada, Sergio; Eriksson, Olof et al.

Part of International Journal of Oncology, p. 1998-2008, 2014

• DOI for Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution
• Download full text (pdf) of Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule

Orlova, Anna; Malm, Magdalena; Rosestedt, Maria; Varasteh, Zohreh et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1450-1459, 2014

• DOI for Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule
• Download full text (pdf) of Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule

Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde

Rosik, Daniel; Thibblin, Alf; Antoni, Gunnar; Honarvar, Hadis et al.

Part of Bioconjugate chemistry, p. 82-92, 2014

• DOI for Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde
• Download full text (pdf) of Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

Sandin, Linda; Orlova, Anna; Gustafsson, Erika; Ellmark, Peter et al.

Part of Cancer Immunology Research, p. 80-90, 2014

• DOI for Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer
• Download full text (pdf) of Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment

Altai, Mohamed; Wållberg, Helena; Honarvar, Hadis; Strand, Joanna et al.

Part of Journal of Nuclear Medicine, p. 1842-1848, 2014

• DOI for ¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment
• Download full text (pdf) of ¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment

Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Hosseinimehr, Seyed Jalal et al.

Part of Journal of Nuclear Medicine, p. 294-300, 2014

• DOI for Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591
• Download full text (pdf) of Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591

Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine

Altai, Mohamed; Orlova, Anna; Tolmachev, Vladimir

Part of Current pharmaceutical design, p. 2275-2292, 2014

• DOI for Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re

Altai, Mohamed; Honarvar, Hadis; Wållberg, Helena; Strand, Joanna et al.

Part of European Journal of Medicinal Chemistry, p. 519-528, 2014

• DOI for Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re
• Download full text (pdf) of Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule

Sörensen, Jens; Sandberg, Dan; Sandström, Mattias; Wennborg, Anders et al.

Part of Journal of Nuclear Medicine, p. 730-735, 2014

• DOI for First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule
• Download full text (pdf) of First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule

Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo

Strand, Joanna; Varasteh, Zohreh; Eriksson, Olof; Abrahmsen, Lars et al.

Part of Molecular Pharmaceutics, p. 3957-3964, 2014

• DOI for Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo

Gallium-68-labeled affibody molecule for PET imaging of PDGFR beta expression in vivo

Strand, Joanna; Varasteh, Zohreh; Eriksson, Olof; Abrahmsen, L. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Influence of chelators on biodistribution and targeting properties of GRPR antagonist

Mitran, Bogdan; Varasteh, Zohreh; Rosestedt, Maria; Velikyan, Irina et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

In vivo characterization of a novel engineered CD44v6-targeting bivalent antibody fragment AbD19384 for molecular imaging of squamous cell carcinoma

Mortensen, Anja C.; Spegelberg, Diana; Haylock, Anna-Karin; Selvaraju, Ram Kumar et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

PET Imaging of HER3-Expression in Tumours Using a 68Ga-Labeled Affibody Molecule

Rosestedt, Maria; Andersson, K.; Lofblom, J.; Mitran, Bogdan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Evaluation of 99mTc-ZIGF1R:4551-GGGC Affibody Molecule, a New Construct for Imaging the Insulin-like Growth Factor Type 1 Receptor Expression

Mitran, Bogdan; Altai, M.; Hofstrom, C.; Honarvar, Hadis et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-Z09781 Affibody molecule

Honarvar, Hadis; Garousi, Javad; Gunneriusson, E.; Hoiden-Guthenberg, I. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

[^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

Orlova, Anna; Hofström, Camilla; Strand, Joanna; Varasteh, Zohreh et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 439-449, 2013

• DOI for [^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
• Download full text (pdf) of [^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

Specific Uptake of an Amyloid-beta Protofibril-Binding Antibody-Tracer in A beta PP Transgenic Mouse Brain

Magnusson, Kristina; Sehlin, Dag; Syvänen, Stina; Svedberg, Marie M. et al.

Part of Journal of Alzheimer's Disease, p. 29-40, 2013

• DOI for Specific Uptake of an Amyloid-beta Protofibril-Binding Antibody-Tracer in A beta PP Transgenic Mouse Brain

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Gudmundsdotter, Lindvi et al.

Part of PLOS ONE, 2013

• DOI for Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
• Download full text (pdf) of Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts

Strand, Joanna; Honarvar, Hadis; Perols, Anna; Orlova, Anna et al.

Part of PLOS ONE, 2013

• DOI for Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts
• Download full text (pdf) of Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts

In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

Varasteh, Zohreh; Åberg, Ola; Velikyan, Irina; Lindeberg, Gunnar et al.

Part of PLOS ONE, 2013

• DOI for In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
• Download full text (pdf) of In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA

Altai, Mohamed; Strand, Joanna; Rosik, Daniel; Selvaraju, Ram Kumar et al.

Part of Bioconjugate chemistry, p. 1102-1109, 2013

• DOI for Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA
• Download full text (pdf) of Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA

Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein

Orlova, Anna; Jonsson, Andreas; Rosik, Daniel; Lundqvist, Hans et al.

Part of Journal of Nuclear Medicine, p. 961-968, 2013

• DOI for Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
• Download full text (pdf) of Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules

Hofström, Camilla; Altai, Mohamed; Honarvar, Hadis; Strand, Joanna et al.

Part of Journal of Medicinal Chemistry, p. 4966-4974, 2013

• DOI for HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules
• Download full text (pdf) of HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules

Feasibility of radionuclide imaging of HER3-expressing tumors using affibody molecules

Orlova, Anna; Malm, Magdalena; Lindberg, Hanna; Varasteh, Zohreh et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2013

(AlF)-F-18-labelling of NOTA-P2-RM26 and its evaluation as a PET ligand for GRPR/BB2

Åberg, Ola; Varasteh, Zohreh; Lindeberg, Gunnar; Larhed, Mats et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2013

Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar; Sörensen, Jens et al.

Part of Bioconjugate chemistry, p. 1144-1153, 2013

• DOI for Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging
• Download full text (pdf) of Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

GRPR antagonist NOTA-P2-RM26 labeled with fluorine-18: radiochemistry, in vitro and in vivo evaluation

Varasteh, Zohreh; Åberg, Ola; Lindberg, G.; Antoni, Gunnar et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

Imaging of PDGFRbeta expression in vivo using Affibody molecule In-111-DOTA-Z09591

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Hosseinimehr, S. Jalal et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

HAHAHA-, HIHIHI-. HKHKHK. HHHHHH- and HEHEHE- tags: Influence of position and composition of histidine-containing tags on biodistribution of [99mTc(CO) 3]+- labeled affibody molecules

Tolmachev, Vladimir; Hofstrom, C.; Altai, Mohamed; Honarvar, Hadis et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging

Honarvar, Hadis; Jokilaakso, Nima; Andersson, Karl; Malmberg, Jennie et al.

Part of Nuclear Medicine and Biology, p. 378-386, 2013

• DOI for Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging
• Download full text (pdf) of Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging

Influence of macrocyclic chelators on biodistribution and targeting properties of 68Ga-labeled synthetic Affibody molecules. Comparison with 111In-labeled counterparts

Strand, Joanna; Honarvar, Hadis; Perols, A.; Orlova, Anna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

Feasibility of radionuclide imaging of HER3-expressing tumours using technetium-99m labeled affibody molecules

Orlova, Anna; Malm, M.; Lindberg, H.; Varasteh, Zohreh et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

Selection of an optimal cysteine-containing peptide-based chelator for labeling of Affibody molecules with 188-Re

Altai, Mohamed; Honarvar, Hadis; Wållberg, Helena; Strand, Joanna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

• DOI for Selection of an optimal cysteine-containing peptide-based chelator for labeling of Affibody molecules with 188-Re

In vivo imaging of PDGFR beta expression using In-111-DOTA-Z09591 Affibody molecule

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Eriksson, Olof et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2013

Direct comparison of In-111-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging

Rosik, Daniel; Orlova, Anna; Malmberg, Jennie; Altai, Mohamed et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 693-702, 2012

• DOI for Direct comparison of In-111-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging

Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with ¹¹¹In using a maleimido derivative of NODAGA

Altai, Mohamed; Perols, Anna; Eriksson Karlström, Amelie; Sandström, Mattias et al.

Part of Nuclear Medicine and Biology, p. 518-529, 2012

• DOI for Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with ¹¹¹In using a maleimido derivative of NODAGA

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.

Malmberg, Jennie; Perols, Anna; Varasteh, Zohreh; Altai, Mohamed et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 481-492, 2012

• DOI for Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.

Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line

Barta, Pavel; Malmberg, Jennie; Melicharova, Ludmila; Strandgård, John et al.

Part of International Journal of Oncology, p. 1677-1682, 2012

• DOI for Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

Hosseinimehr, Seyed Jalal; Tolmachev, Vladimir; Orlova, Anna

Part of Drug Discovery Today, p. 1224-1232, 2012

• DOI for Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule ¹¹¹In-DOTA-Z_IGF1R:4551

Tolmachev, Vladimir; Malmberg, Jennie; Hofström, Camilla; Abrahmsén, Lars et al.

Part of Journal of Nuclear Medicine, p. 90-97, 2012

• DOI for Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule ¹¹¹In-DOTA-Z_IGF1R:4551

Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with ¹⁸F-Labeled Affibody Molecule Z_HER2:2395 in a Mouse Model for Ovarian Cancer

Heskamp, Sandra; Laverman, Peter; Rosik, Daniel; Boschetti, Frederic et al.

Part of Journal of Nuclear Medicine, p. 146-153, 2012

• DOI for Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with ¹⁸F-Labeled Affibody Molecule Z_HER2:2395 in a Mouse Model for Ovarian Cancer

Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

Tolmachev, Vladimir; Tran, Thuy A; Rosik, Daniel; Sjöberg, Anna et al.

Part of Journal of Nuclear Medicine, p. 953-960, 2012

• DOI for Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules

Honarvar, Hadis; Perols, A.; Strand, Joanna; Selvaraju, Ram Kumar et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Development of 124I-labelled anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer

Malmberg, Jennie; Selvaraju, Ram Kumar; Tolmachev, Vladimir; Orlova, Anna

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

99mTc(CO)3-HEHEHE-ZIGF1R:4551 affibody molecule, a poteintial imaging agent for visualization of insulin-like growth factor-1 receptor in malignant tumors

Tolmachev, Vladimir; Hofstrom, C.; Strand, J.; Varasteh, Zohreh et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of (99m)Tc-labeled recombinant Affibody molecules

Altai, Mohamed; Wållberg, Helena; Orlova, Anna; Rosestedt, Maria et al.

Part of Amino Acids, p. 1975-1985, 2012

• DOI for Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of (99m)Tc-labeled recombinant Affibody molecules

Molecular imaging using the Affibody molecule [111In]ABY-025 can identify the HER2 status in breast cancer patients

Sandberg, Dan; Feldwisch, J.; Wennborg, A.; Tolmachev, Vladimir et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Site-specific radioiodination of HER2-targeting affibody molecules using iodophenetylmaleimide decreases renal uptake of radioactivity

Strand, Joanna; Nordeman, Patrik; Honarvar, Hadis; Altai, Mohamed et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Synthesis and characterization of a high affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging

Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar; Sörensen, Jens et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for ^99mTc-labelling at the C terminus

Lindberg, Hanna; Hofström, Camilla; Altai, Mohamed; Honorvar, Hadis et al.

Part of Tumor Biology, p. 641-651, 2012

• DOI for Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for ^99mTc-labelling at the C terminus

Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of In-111-Labeled Synthetic Anti-HER2 Affibody Molecules

Perols, Anna; Honarvar, Hadis; Strand, Joanna; Selvaraju, Ramkumar et al.

Part of Bioconjugate chemistry, p. 1661-1670, 2012

• DOI for Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of In-111-Labeled Synthetic Anti-HER2 Affibody Molecules

Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA

Altai, Mohamed; Strand, Joanna; Rosik, D.; Selvaraju, Ram Kumar et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone

Evans-Axelsson, Susan; Ulmert, David; Orbom, Anders; Peterson, Pernilla et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 243-251, 2012

• DOI for Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone

Engineering of affibody molecules for therapy and diagnostics

Feldwisch, Joachim; Tolmachev, Vladimir

Part of Methods in molecular biology, p. 103-126, 2012

• DOI for Engineering of affibody molecules for therapy and diagnostics

Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [In-111]-labeled affibody molecule Z(EGFR:2377) and cetuximab

Malmberg, Jennie; Tolmachev, Vladimir; Orlova, Anna

Part of International Journal of Oncology, p. 1137-1143, 2011

• DOI for Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [In-111]-labeled affibody molecule Z(EGFR:2377) and cetuximab

Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [In-111]-labeled CHX-A "DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines

Malmberg, Jennie; Tolmachev, Vladimir; Orlova, Anna

Part of Experimental and Therapeutic Medicine, p. 523-528, 2011

• DOI for Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [In-111]-labeled CHX-A "DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines

Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand

Wållberg, Helena; Löfdahl, Per K.; Tschapalda, Kirsten; Uhlén, Mathias et al.

Part of Protein Expression and Purification, p. 127-135, 2011

• DOI for Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand

Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

Wållberg, Helena; Orlova, Anna; Altai, Mohammed; Hosseinimehr, Seyed Jalal et al.

Part of Journal of Nuclear Medicine, p. 461-469, 2011

• DOI for Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

Improved Tumor-to-Organ Ratios of a Novel ⁶⁷Ga-Human Epidermal Growth Factor Radionuclide Conjugate with Preadministered Antiepidermal Growth Factor Receptor Affibody Molecules

Sandström, Karl; Haylock, Anna-Karin; Velikyan, Irina; Spiegelberg, Diana et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 593-601, 2011

• DOI for Improved Tumor-to-Organ Ratios of a Novel ⁶⁷Ga-Human Epidermal Growth Factor Radionuclide Conjugate with Preadministered Antiepidermal Growth Factor Receptor Affibody Molecules

Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with Tc-99m, In-111 and I-125

Hofström, Camilla; Orlova, Anna; Altai, Mohamed; Wångsell, Fredrik et al.

Part of Journal of Medicinal Chemistry, p. 3817-3826, 2011

• DOI for Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with Tc-99m, In-111 and I-125

Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Tolmachev, Vladimir; Altai, Mohamed; Sandström, Mattias; Perols, Anna et al.

Part of Bioconjugate chemistry, p. 894-902, 2011

• DOI for Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Engineering of C-terminal cysteine-containing peptide-based chelators improves biodistribution of HER2-targeting ^99mTc-labeled Affibody molecules

Wållberg, H; Orlova, Anna; Altai, Mohammed; Hosseinimehr, Seyed Jalal et al.

Part of Journal of Nuclear Medicine, p. 461-469, 2011

• DOI for Engineering of C-terminal cysteine-containing peptide-based chelators improves biodistribution of HER2-targeting ^99mTc-labeled Affibody molecules

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

Andersen, Jan Terje; Pehrson, Rikard; Tolmachev, Vladimir; Daba, Muluneh Bekele et al.

Part of Journal of Biological Chemistry, p. 5234-5241, 2011

• DOI for Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate

Tolmachev, Vladimir; Feldwisch, Joachim; Lindborg, Malin; Baastrup, Barbro et al.

Part of Nuclear Medicine and Biology, p. 697-706, 2011

• DOI for Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Tolmachev, Vladimir; Wållberg, Helena; Sandström, Mattias; Hansson, Monika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 531-539, 2011

• DOI for Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

(125)I-Labeled Quercetin as a Novel DNA-Targeted Radiotracer

Hosseinimehr, Seyed Jalal; Tolmachev, Vladimir; Stenerlöw, Bo

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 469-475, 2011

• DOI for (125)I-Labeled Quercetin as a Novel DNA-Targeted Radiotracer

Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas

Nestor, Marika; Sundström, Magnus; Anniko, Matti; Tolmachev, Vladimir

Part of Nuclear Medicine and Biology, p. 103-112, 2011

• DOI for Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas

Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on (111)In- and (125)I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody

Malmberg, Jennie; Sandström, Mattias; Wester, Kenneth; Tolmachev, Vladimir et al.

Part of Nuclear Medicine and Biology, p. 1093-1102, 2011

• DOI for Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on (111)In- and (125)I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody

Radiobromine-labelled tracers for positron emission tomography: possibilities and pitfalls

Tolmachev, Vladimir

Part of Current radiopharmaceuticals, p. 76-89, 2011

• DOI for Radiobromine-labelled tracers for positron emission tomography: possibilities and pitfalls

Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets

Tolmachev, Vladimir; Orlova, Anna

Part of Current Medicinal Chemistry, p. 2636-2655, 2010

• DOI for Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets

Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.

Hosseinimehr, Seyed Jalal; Orlova, Anna; Tolmachev, Vladimir

Part of Human antibodies, p. 107-11, 2010

• DOI for Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.

A HER2-binding Affibody molecule labelled with ⁶⁸Ga for PET imaging: direct in vivo comparison with the ¹¹¹In-labelled analogue

Tolmachev, Vladimir; Velikyan, Irina; Sandström, Mattias; Orlova, Anna

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1356-1367, 2010

• DOI for A HER2-binding Affibody molecule labelled with ⁶⁸Ga for PET imaging: direct in vivo comparison with the ¹¹¹In-labelled analogue

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

Tolmachev, Vladimir; Rosik, Daniel; Wållberg, Helena; Sjöberg, Anna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 613-622, 2010

• DOI for Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

Re-186-maSGS-Z(HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours

Orlova, Anna; Tran, Thuy A; Ekblad, Torun; Karlström, Amelie Eriksson et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 260-269, 2010

• DOI for Re-186-maSGS-Z(HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours

Design of an optimized scaffold for affibody molecules.

Feldwisch, Joachim; Tolmachev, Vladimir; Lendel, Christofer; Herne, Nina et al.

Part of Journal of Molecular Biology, p. 232-247, 2010

• DOI for Design of an optimized scaffold for affibody molecules.

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules

Baum, Richard P; Prasad, Vikas; Müller, Dirk; Schuchardt, Christiane et al.

Part of Journal of Nuclear Medicine, p. 892-897, 2010

• DOI for Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules

HEHEHE: a new chelator for [Tc-99m(CO)(3)](+)-labeling assembling His(6)-tag in protein purification

Tolmachev, Vladimir; Hofström, Camilla; Malmberg, Jennie; Ahlgren, Sara et al.

Part of Nuclear Medicine and Biology, p. 698-698, 2010

• DOI for HEHEHE: a new chelator for [Tc-99m(CO)(3)](+)-labeling assembling His(6)-tag in protein purification

HER2 targeting with Tc-99m-labeled second generation synthetic Affibody molecule

Tolmachev, Vladimir; Wallberg, Helena; Feldwisch, Joachim; Orlova, Anna

Part of Nuclear Medicine and Biology, p. 705-706, 2010

• DOI for HER2 targeting with Tc-99m-labeled second generation synthetic Affibody molecule

Influence of an aliphatic linker between DOTA and synthetic Affibody molecule on targeting properties

Orlova, Anna; Feldwisch, Joachim; Tolmachev, Vladimir

Part of Nuclear Medicine and Biology, p. 695-695, 2010

• DOI for Influence of an aliphatic linker between DOTA and synthetic Affibody molecule on targeting properties

HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [Tc-99m(CO)(3)](+), and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Tolmachev, Vladimir; Hofström, Camilla; Malmberg, Jennie; Ahlgren, Sara et al.

Part of Bioconjugate chemistry, p. 2013-2022, 2010

• DOI for HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [Tc-99m(CO)(3)](+), and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Targeting of HER2-Expressing Tumors Using ¹¹¹In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Ahlgren, Sara; Orlova, Anna; Wållberg, Helena; Hansson, Monika et al.

Part of Journal of Nuclear Medicine, p. 1131-1138, 2010

• DOI for Targeting of HER2-Expressing Tumors Using ¹¹¹In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Kit formulation for ^99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine

Ahlgren, Sara; Andersson, Kristofer; Tolmachev, Vladimir

Part of Nuclear Medicine and Biology, p. 539-546, 2010

• DOI for Kit formulation for ^99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine

The use of closo-dodecaborate-containing linker improves targeting of HNSCC xenografts with radioiodinated chimeric monoclonal antibody U36

Cheng, Junping; Engström, Mats; Ekberg, Tomas; Nestor, Marika et al.

Part of Molecular Medicine Reports, p. 155-160, 2010

• DOI for The use of closo-dodecaborate-containing linker improves targeting of HNSCC xenografts with radioiodinated chimeric monoclonal antibody U36

The influence of Bz-DOTA and CHX-AaEuro(3)-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for In-114m-mediated targeting therapy

Tolmachev, Vladimir; Wallberg, Helena; Andersson, Karl; Wennborg, Anders et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1460-1468, 2009

• DOI for The influence of Bz-DOTA and CHX-AaEuro(3)-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for In-114m-mediated targeting therapy

Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging

Tran, Thuy A.; Rosik, Daniel; Abrahmsén, Lars; Sandström, Mattias et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1864-1873, 2009

• DOI for Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging

Reply: Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression

Tolmachev, Vladimir

Part of Journal of Nuclear Medicine, p. 1196-1196, 2009

• DOI for Reply: Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding

Tolmachev, Vladimir; Mume, Eskender; Sjöberg, Stefan; Frejd, Fredrik Y. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 692-701, 2009

• DOI for Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding

Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

Tolmachev, Vladimir; Friedman, Mikaela; Sandström, Mattias; Eriksson, Tove L. et al.

Part of Journal of Nuclear Medicine, p. 274-283, 2009

• DOI for Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of ¹²⁴I-labelled Affibody molecule and trastuzumab in a murine xenograft model

Orlova, Anna; Wållberg, Helena; Stone-Elander, Sharon; Tolmachev, Vladimir

Part of European Journal of Nuclear Medicine, p. 417-425, 2009

• DOI for On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of ¹²⁴I-labelled Affibody molecule and trastuzumab in a murine xenograft model

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine

Ahlgren, Sara; Wållberg, Helena; Tran, Thuy A.; Widström, Charles et al.

Part of Journal of Nuclear Medicine, p. 781-789, 2009

• DOI for Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine

Synthesis and chemoselective intramolecular cross-linking of a HER2-binding Affibody

Ekblad, Torun; Tolmachev, Vladimir; Orlova, Anna; Lendel, Christofer et al.

Part of Biopolymers, p. 116-123, 2009

• DOI for Synthesis and chemoselective intramolecular cross-linking of a HER2-binding Affibody

Positioning of Tc-99m-chelators influences radiolabeling, stability and biodistribution of Affibody molecules

Ekblad, Torun; Orlova, Anna; Feldwisch, Joachim; Wennborg, Anders et al.

Part of Bioorganic & Medicinal Chemistry Letters, p. 3912-3914, 2009

• DOI for Positioning of Tc-99m-chelators influences radiolabeling, stability and biodistribution of Affibody molecules

Update on Affibody molecules for in vivo imaging of targets for cancer therapy

Tolmachev, V; Orlova, A

Part of Minerva biotecnologica (Testo stampato), p. 21-30, 2009

Differences in radiosensitivity between three HER2 overexpressing cell lines

Steffen, Ann-Charlott; Göstring, Lovisa; Tolmachev, Vladimir; Palm, Stig et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1179-1191, 2008

• DOI for Differences in radiosensitivity between three HER2 overexpressing cell lines

In vivo and in vitro uptake of In-111, delivered with the affibody molecule(Z(EGFR:955))(2), in EGFR expressing tumour cells

Nordberg, Erika; Orlova, Anna; Friedman, M.; Tolmachev, Vladimir et al.

Part of Oncology Reports, p. 853-857, 2008

Targeting EGFR and HER2 with 211At-labeled molecules: unexpected and expected dose-effect relations in cultured tumor cells

Carlsson, Jörgen; Steffen, Ann-Charlott; Sundberg, Åsa L.; Vikström, Mikael et al.

Part of Current radiopharmaceuticals, p. 225-233, 2008

Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of ^99mTc-labeled anti-HER2 Affibody molecules

Tran, Thuy; Ekblad, Torun; Orlova, Anna; Sandström, Mattias et al.

Part of Bioconjugate chemistry, p. 2568-2576, 2008

• DOI for Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of ^99mTc-labeled anti-HER2 Affibody molecules

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

Ahlgren, Sara; Orlova, Anna; Rosik, Daniel; Sandström, Mattias et al.

Part of Bioconjugate chemistry, p. 235-243, 2008

• DOI for Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

Tolmachev, Vladimir; Xu, Heng; Wållberg, Helena; Ahlgren, Sara et al.

Part of Bioconjugate chemistry, p. 1579-1587, 2008

• DOI for Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

Friedman, Mikaela; Orlova, Anna; Johansson, Eva; Eriksson, Tove L. J. et al.

Part of Journal of Molecular Biology, p. 1388-1402, 2008

• DOI for Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

Ekblad, Torun; Tran, Thuy; Orlova, Anna; Widström, Charles et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 2245-2255, 2008

• DOI for Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors

Orlova, Anna; Tran, Thuy; Widström, Charles; Engfeldt, Torun et al.

Part of International Journal of Molecular Medicine, p. 397-404, 2007

In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules

Thuy, Tran; Engfeldt, Torun; Orlova, Anna; Widström, Charles et al.

Part of Bioconjugate chemistry, p. 549-558, 2007

• DOI for In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules
• Download full text (pdf) of In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules

Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay

Nestor, Marika; Ekberg, Tomas; Dring, John; van Dongen, Guus et al.

Part of Tumor Biology, p. 253-263, 2007

• DOI for Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay

[Lu-177]pertuzumab: Experimental therapy of HER-2-expressing xenografts

Persson, Mikael; Gedda, Lars; Lundqvist, Hans; Tolmachev, Vladimir et al.

Part of Cancer Research, p. 326-331, 2007

• DOI for [Lu-177]pertuzumab: Experimental therapy of HER-2-expressing xenografts

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule

Tolmachev, Vladimir; Orlova, Anna; Pehrson, Rikard; Galli, Joakim et al.

Part of Cancer Research, p. 2773-2782, 2007

• DOI for Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule

Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma

Fortin, Marc-André; Orlova, Anna; Malmström, Per-Uno; Tolmachev, Vladimir

Part of International Journal of Molecular Medicine, p. 285-291, 2007

^99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

Engfeldt, Torun; Tran, Thuy; Orlova, Anna; Widström, Charles et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1843-1853, 2007

• DOI for ^99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors

Tran, Thuy; Engfeldt, Torun; Orlova, Anna; Sandström, Mattias et al.

Part of Bioconjugate chemistry, p. 1956-1964, 2007

• DOI for (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors

Biodistribution of At-211-Labeled humanized monoclonal antibody A33

Almqvist, Ylva; Steffen, Ann-Charlott; Lundqvist, Hans; Jensen, Holger et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 480-487, 2007

• DOI for Biodistribution of At-211-Labeled humanized monoclonal antibody A33

Update: Affibody molecules for molecular imaging and therapy for cancer

Orlova, Anna; Feldwisch, Joachim; Abrahmsén, Lars; Tolmachev, Vladimir

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 573-584, 2007

• DOI for Update: Affibody molecules for molecular imaging and therapy for cancer

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

Engfeldt, Torun; Orlova, Anna; Tran, Thuy; Bruskin, Alexander et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 722-733, 2007

• DOI for Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors

Orlova, Anna; Rosik, Daniel; Sandström, Mattias; Lundqvist, Hans et al.

Part of The Quarterly Journal of Nuclear Medicine and Molecular Imaging, p. 314-323, 2007

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

Orlova, Anna; Tolmachev, Vladimir; Pehrson, Rikard; Lindborg, Malin et al.

Part of Cancer Research, p. 2178-2186, 2007

• DOI for Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

In vitro evaluation of two polyhedral boron anion derivatives as linkers for attachment of radioiodine to the anti-HER2 monoclonal antibody trastuzumab

Persson, Mikael; Sivaev, Igor; Winberg, Karl-Johan; Gedda, Lars et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 585-596, 2007

• DOI for In vitro evaluation of two polyhedral boron anion derivatives as linkers for attachment of radioiodine to the anti-HER2 monoclonal antibody trastuzumab

Biodistribution of 211At labeled HER-2 binding affibody molecules in mice

Steffen, Ann-Charlott; Almqvist, Ylva; Chyan, Ming-Kuan; Lundqvist, Hans et al.

Part of Oncology Reports, p. 1141-1147, 2007

Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma

Cheng, Junping; Ekberg, Tomas; Engström, Mats; Nestor, Marika et al.

Part of The Laryngoscope, p. 1013-1018, 2007

• DOI for Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma

Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand

Tran, Thuy; Orlova, Anna; Sivaev, Igor; Sandström, Mattias et al.

Part of International Journal of Molecular Medicine, p. 485-493, 2007

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors

Tolmachev, Vladimir; Nilsson, Fredrik Y.; Widström, Charles; Andersson, Karl et al.

Part of Journal of Nuclear Medicine, p. 846-53, 2006

Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours

Persson, Mikael I.; Gedda, Lars; Jensen, H. J.; Lundqvist, Hans et al.

Part of Oncology Reports, p. 673-80, 2006

Planning for intracavitary anti-EGFR radionuclide therapy of gliomas: Literature review and data on EGFR expression

Carlsson, Jörgen; Ren, Z. P.; Wester, K.; Sundberg, A. L. et al.

Part of Journal of Neuro-Oncology, p. 33-45, 2006

• DOI for Planning for intracavitary anti-EGFR radionuclide therapy of gliomas: Literature review and data on EGFR expression

In vitro and in vivo characterization of 177Lu‑huA33: A radioimmunoconjugate against colorectal cancer

Almqvist, Ylva; Steffen, Ann-Charlott; Tolmachev, Vladimir; Divgi, Chaitanya R. et al.

Part of Nuclear Medicine and Biology, p. 991-998, 2006

• DOI for In vitro and in vivo characterization of 177Lu‑huA33: A radioimmunoconjugate against colorectal cancer

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

Steffen, Ann-Charlott; Orlova, Anna; Wikman, Maria; Nilsson, Fredrik Y. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 631-638, 2006

• DOI for Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors

Orlova, Anna; Nilsson, Fredrik Y.; Wikman, Maria; Widström, Charles et al.

Part of Journal of Nuclear Medicine, p. 512-519, 2006

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Orlova, Anna; Magnusson, Mikaela; Eriksson, Tove L. J.; Nilsson, Martin et al.

Part of Cancer Research, p. 4339-48, 2006

• DOI for Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenated

Höglund, Johanna; Orlova, Anna; Sundin, Anders; Lundqvist, Hans et al.

Part of Oncology Reports, p. 159-63, 2006

Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)

Orlova, Anna; Bruskin, Alexander; Sivaev, Igor; Sjöberg, Stefan et al.

Part of Anticancer Research, p. 1217-23, 2006

Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives

Ghirmai, Senait; Mume, Eskender; Tolmachev, Vladimir; Sjöberg, Stefan

Part of Carbohydrate Research, p. 15-24, 2005

• DOI for Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives

An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assay

Kullberg, Erika Bohl; Stenerlöw, Bo; Ghirmai, Senait; Lundqvist, Hans et al.

Part of International Journal of Oncology, p. 1355-60, 2005

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells

Persson, Mikael; Tolmachev, Vladimir; Andersson, Karl; Gedda, Lars et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1457-62, 2005

• DOI for [(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells

An Aminoacridine Derivative for Radionuclide Therapy: Dna-Binding Properties Studied in a Novel Cell-Free in vitro Assay

Kullberg, E-B.; Stenerlöw, B.; Ghirmait, Senait; Lundqvist, Hans et al.

Part of Int. J. Onc., p. 1355-1360, 2005

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualisation of EGFR expression in malignant tumours

Velikyan, Irina; Liljegren Sundberg, Åsa; Lindhe, Örjan; Höglund, A Urban et al.

Part of Journal of Nuclear Medicine, p. 1881-1888, 2005

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

Steffen, Ann-Charlott; Wikman, Maria; Tolmachev, Vladimir; Adams, Gregory P. et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 239-248, 2005

Synthesis and radioiodination of some 9-aminoacridine derivatives for potential use in radionuclide therapy

Ghirmai, Senait; Mume, Eskender; Lundqvist, Hans; Tolmachev, Vladimir et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 855-871, 2005

• DOI for Synthesis and radioiodination of some 9-aminoacridine derivatives for potential use in radionuclide therapy

[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation

Babaei, Mohammad Hossein; Almqvist, Ylva; Orlova, Anna; Shafii, Mohammad et al.

Part of Oncology Reports, p. 1169-75, 2005

Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody

Mume, Eskender; Orlova, Anna; Larsson, Barbro; Nilsson, Ann-Sofie et al.

Part of Bioconjugate chemistry, p. 1547-1555, 2005

• DOI for Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

Nestor, Marika; Persson, Mikael; van Dongen, Guus A.; Jensen, Holger J. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1296-304, 2005

• DOI for In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

Almqvist, Ylva; Orlova, Anna; Sjöström, Anna; Jensen, Holger J. et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 514-523, 2005

• DOI for In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET

Mume, Eskender; Orlova, Anna; Malmström, Per-Uno; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 613-22, 2005

• DOI for Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET

Radiobromination of closo-carboranes using palladium-catalyzed halogen exchange

Winberg, Karl Johan; Mume, Eskender; Tolmachev, Vladimir; Sjöberg, Stefan

Part of Journal of labelled compounds & radiopharmaceuticals, p. 195-202, 2005

• DOI for Radiobromination of closo-carboranes using palladium-catalyzed halogen exchange

Radionuklidterapi - möjlig väg mot bättre behandling av cancer: Hindret är bristen på kommersiellt tillgängliga nuklider i kliniken

Lundqvist, Hans; Carlsson, Jörgen; Gedda, Lars; Tolmachev, Vladimir et al.

Part of Läkartidningen, p. 1000-1006, 2004

[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma

Sundberg, Åsa Liljegren; Gedda, Lars; Orlova, Anna; Bruskin, Alexander et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 195-204, 2004

• DOI for [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma

Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

Tolmachev, Vladimir; Orlova, Anna; Wei, Qichun; Bruskin, Alexander et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 491-501, 2004

• DOI for Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

Synthesis and Radioiodination of 7-(3´-Ammoniopropyl)-7,8-dicarba-nido-undecaborate(-1), (ANC)

Ghirmai, Senait; Malmquist, Jonas; Lundquist, Hans; Tolmachev, Vladimir et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 557-569, 2004

• DOI for Synthesis and Radioiodination of 7-(3´-Ammoniopropyl)-7,8-dicarba-nido-undecaborate(-1), (ANC)

Selection and characterization of HER2/neu-binding affibody ligands

Wikman, Maria; Steffen, Ann-Charlott; Gunneriusson, Elin; Tolmachev, Vladimir et al.

Part of Protein Engineering Design & Selection, p. 455-462, 2004

• DOI for Selection and characterization of HER2/neu-binding affibody ligands

Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT

Sandström, Mattias; Tolmachev, Vladimir; Kairemo, Kalevi; Lundqvist, Hans et al.

Part of Physics in Medicine and Biology, p. 5419-32, 2004

• DOI for Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT

Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion

Winberg, Karl Johan; Persson, Mikael; Malmström, Per-Uno; Sjöberg, Stefan et al.

Part of Nuclear Medicine and Biology, p. 425-33, 2004

• DOI for Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion

Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI)

Bruskin, Alexander; Sivaev, Igor; Persson, Mikael; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 205-11, 2004

A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy: availability of suitable radionuclides

Tolmachev, Vladimir; Carlsson, Jörgen; Lundqvist, Hans

Part of Acta Oncologica, p. 264-75, 2004

Targeting against epidermal growth factor receptors: Cellular processing of astatinated EGF after binding to cultured carcinoma cells

Orlova, Anna; Sjöström, Anna; Lebeda, Ondrej; Lundqvist, Hans et al.

Part of Anticancer Research, p. 4035-4042, 2004

Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker

Cheng, Junping; Persson, Mikael; Tolmachev, Vladimir; Siavaev, Igor et al.

Part of Acta Oto-Laryngologica, p. 1078-85, 2004

Copper-mediated isotopic exchange between [125I]iodide and bis(triethylammonium) undecahydro-12-iodo-closo-dodecaborate in aqueous media

Schukin, E.; Orlova, Anna; Korsakov, M.; Sjöberg, Stefan et al.

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 295-299, 2004

• DOI for Copper-mediated isotopic exchange between [125I]iodide and bis(triethylammonium) undecahydro-12-iodo-closo-dodecaborate in aqueous media

Preparation, radioiodination, and in vitro evaluation of a nido-carborane-dextran conjugate, a potential residualizing label for tumor targeting proteins and peptides

Tolmachev, Vladimir; Bruskin, Alexander; Sjöberg, Stefan; Carlsson, Jörgen et al.

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 107-112, 2004

• DOI for Preparation, radioiodination, and in vitro evaluation of a nido-carborane-dextran conjugate, a potential residualizing label for tumor targeting proteins and peptides

Radioiodination of ammonio-closo-monocarborane, 1-H3N-1-CB1 H11: Aspects of labelling chemistry in aqueous solution using Chloramine-T

Orlova, Anna; Sivaev, I.; Sjöberg, Stefan; Lundqvist, Hans et al.

Part of Radiochimica Acta, p. 311, 2004

Synthesis and Radioiodination of Some 9-Aminoacridine Derivatives

Ghirmai, Senait; Mume, Eskender; Henssen, Cecile; Ghaneolhusseini, Hadi et al.

Part of European Journal of Organic Chemistry, p. 3719-3725, 2004

• DOI for Synthesis and Radioiodination of Some 9-Aminoacridine Derivatives

[111In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent

Sundberg, Åsa Liljegren; Orlova, Anna; Bruskin, Alexander; Gedda, Lars et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 643-54, 2003

• DOI for [111In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF

Sundberg, Åsa Liljegren; Almqvist, Ylva; Orlova, Anna; Blomquist, Erik et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1348-56, 2003

• DOI for Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF

Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker: Comparison with other radioiodination methods

Nestor, Marika; Persson, Mikael; Cheng, Junping; Tolmachev, Vladimir et al.

Part of Bioconjugate chemistry, p. 805-10, 2003

• DOI for Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker: Comparison with other radioiodination methods

Pharmacokinetics and red cell utilization of ⁵²Fe/⁵⁹Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

Beshara, Soheir; Sörensen, Jens; Lubberink, Mark; Tolmachev, Vladimir et al.

Part of British Journal of Haematology, p. 853-859, 2003

• DOI for Pharmacokinetics and red cell utilization of ⁵²Fe/⁵⁹Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

Feasibility of palladium catalysed isotopic exchange between [125I]iodide and 2-iodo-para-carborane

Eriksson, Ludvig; Tolmachev, Vladimir; Sjöberg, Stefan

Part of Journal of labelled compounds & radiopharmaceuticals, p. 623-631, 2003

• DOI for Feasibility of palladium catalysed isotopic exchange between [125I]iodide and 2-iodo-para-carborane

Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

Beshara, Soheir; Sörensen, Jens; Lubberink, Mark; Tolmachev, Vladimir et al.

Part of British Journal of Haematology, p. 853-859, 2003

• DOI for Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

Feasibility of isotopic exchange in system [125I] iodide – undecahydro-iodo-closo-dodecaborate (2-) anion

Korsakov, M. V.; Shchukin, E. V.; Korsakova, L. N.; Orlova, Anna M. et al.

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 67-71, 2003

Treatment of cultured glioma cells with EGFR-TKI gefitinib (‘Iressa’, ZD1839) increases the uptake of astatinated EGF despite absence of gefitinib-mediated growth inhibition

Sundberg, Åsa Liljegren; Almquist, Ylva; Tolmachev, Vladimir; Carlsson, Jörgen

Part of European Journal of Nuclear Medicine, p. 727-9, 2003

• DOI for Treatment of cultured glioma cells with EGFR-TKI gefitinib (‘Iressa’, ZD1839) increases the uptake of astatinated EGF despite absence of gefitinib-mediated growth inhibition

Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides

Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans

Part of Current Medicinal Chemistry, p. 2447-60, 2003

High yield [125I]-labelling of iodinated carboranes by palladium-catalysed isotopic exchange

Winberg, Karl Johan; Barbera, Gemma; Eriksson, Ludvig; Texidor, Francesc et al.

Part of Journal of Organometallic Chemistry, p. 182-192, 2003

High yield [125 I]Iodide-Labeling of Iodinated Carboranes By Palldium-Catalyzed Isotopic Exchange

Winberg, Karl Johan; Barberà, G; Eriksson, Ludvig; Teixidor, F et al.

Part of Journal of Organometallic Chemistry, p. 188-192, 2003

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

Orlova, Anna; Höglund, Johanna; Lubberink, Mark; Lebeda, Ondrej et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 385-96, 2002

• DOI for Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

Radiobromination of closo-dodecaborate anion. Aspects of labelling chemistry in aqueous solutions using Chloramine-T

Tolmachev, Vladimir; Bruskin, Alexander; Sivaev, Igor; Lundqvist, Hans et al.

Part of Radiochimica Acta, p. 229-235, 2002

Polyhedral boron compounds as potential linkers for attachment of radiohalogens to targeting proteins and peptides:  A review

Tolmachev, Vladimir; Sjöberg, Stefan

Part of Collection of Czechoslovak Chemical Communications, p. 913-935, 2002

Elimination of stabilised hyaluronan from the knee joint in healthy men

Lindqvist, Ulla; Tolmachev, Vladimir; Kairemo, Kalevi; Åström, Gunnar et al.

Part of Clinical Pharmacokinetics, p. 603-13, 2002

Production, PET performance and dosimetric considerations of 134Ce/134La,an Auger electron and positron-emitting generator for radionuclide therapy

Lubberink, Mark; Lundqvist, Hans; Tolmachev, Vladimir

Part of Physics in Medicine and Biology, p. 615-29, 2002

• DOI for Production, PET performance and dosimetric considerations of 134Ce/134La,an Auger electron and positron-emitting generator for radionuclide therapy

Targeting peptides and positron emission tomography

Lundqvist, Hans; Tolmachev, Vladimir

Part of Biopolymers, p. 381-92, 2002

• DOI for Targeting peptides and positron emission tomography

110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET

Lubberink, Mark; Tolmachev, Vladimir; Widström, Charles; Bruskin, Alexander et al.

Part of Journal of Nuclear Medicine, p. 1391-7, 2002

Preparation of [76Br] 5-bromo-2-thiouracil, a positron-emitting melanoma loclizing agent

Tolmachev, Vladimir; Orlova, Anna; Sundin, A

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 409-441, 2002

Separation of two labeled components of [111In] -OctreoScan by HPLC

Bruskin, Alexander; Tolmachev, Vladimir; Westlin, J-E; Lundqvist, Hans

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 95-99, 2001

• DOI for Separation of two labeled components of [111In] -OctreoScan by HPLC

Cellular processing of (125)I- and (111)in-labeled epidermal growth factor(EGF) bound to cultured A431 tumor cells

Orlova, Anna; Bruskin, Alexander; Sjöström, Anna; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 827-35, 2000

• DOI for Cellular processing of (125)I- and (111)in-labeled epidermal growth factor(EGF) bound to cultured A431 tumor cells

Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Höglund, Johanna; Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 837-43, 2000

• DOI for Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Optimization of iodination of [125I]-N-succinimidyl-para-iodobenzoate using Chloromine-T for labeling of proteins

Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans

Part of Journal of Radioanalytical and Nuclear Chemistry, p. 207-213, 2000

Positron emission tomography of experimental melanoma with [⁷⁶Br]5-bromo-2-thiouracil

Mårs, Ulla; Tolmachev, Vladimir; Sundin, Anders

Part of Nuclear Medicine and Biology, p. 845-9, 2000

• DOI for Positron emission tomography of experimental melanoma with [⁷⁶Br]5-bromo-2-thiouracil

Direct astatination of a peptide, human epidermal growth factor, using nido-carborane as a prosthetic group

Sjöström, A.; Tolmachev, Vladimir; Koziorowski, J.; Lebeda, Ondrej et al.

Part of Nuclear medicine communications, p. 594, 2000

114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-phe-octreotide

Tolmachev, Vladimir; Bernhardt, Peter; Forssell-Aronsson, Eva; Lundqvist, Hans

Part of Nuclear Medicine and Biology, p. 183-188, 2000

• DOI for 114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-phe-octreotide

Closo-dodecaborate(2-)anion as a potential prosthetic group for attachment of astatine to proteins: Aspects of the labelling chemistry with Chloramine -T

Orlova, Anna; Lebeda, Ondrej; Tolmachev, Vladimir; Sjöberg, Stefan et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 251-260, 2000

Closo-dodecaborate(2-) as a linker for iodination of macromolecules: Aspects on conjugation chemistry and biodistribution

Tolmachev, Vladimir; Koziorowski, Jacek; Sivaev, Igor; Lundqvist, Hans et al.

Part of Bioconjugate chemistry, p. 338-45, 1999

• DOI for Closo-dodecaborate(2-) as a linker for iodination of macromolecules: Aspects on conjugation chemistry and biodistribution

Conjugate chemistry and cellular processing of EGF-dextran

Carlsson, Jörgen; Blomquist, Erik; Gedda, Lars; Liljegren, Åsa et al.

Part of Acta Oncologica, p. 313-321, 1999

High yield direct ⁷⁶Br-bromination of monoclonal antibodies using Cloramine-T

Sundin, Johanna; Tolmachev, Vladimir; Koziorowski, Jacek; Carlsson, Jörgen et al.

Part of Nuclear Medicine and Biology, p. 923-929, 1999

• DOI for High yield direct ⁷⁶Br-bromination of monoclonal antibodies using Cloramine-T

Positron emission tomography and radioimmunotargeting: aspects ofquantification and dosimetry

Lubberink, Mark; Lundqvist, Hans; Westlin, Jan-Erik; Tolmachev, Vladimir et al.

Part of Acta Oncologica, p. 343-349, 1999

Pharmacokinetics and red cell utilization of iron(III) hydroxide- sucrose complex in anaemic patients: a study using positron emission tomography

Beshara, Soheir; Lundqvist, Hans; Sundin, Johanna; Lubberink, Mark et al.

Part of British Journal of Haematology, p. 296-302, 1999

• DOI for Pharmacokinetics and red cell utilization of iron(III) hydroxide- sucrose complex in anaemic patients: a study using positron emission tomography

Synthesis of N-Succinimidyl 4-[76Br]Bromobenzoate and its Use in Conjugation Labelling of Macromolecules

Yngve, Ulrika; Hedberg, Elisabeth; Lövqvist, Anna; Tolmachev, Vladimir et al.

Part of Acta Chemica Scandinavica, p. 508-512, 1999

• DOI for Synthesis of N-Succinimidyl 4-[76Br]Bromobenzoate and its Use in Conjugation Labelling of Macromolecules

Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography

Beshara, Soheir; Lundqvist, Hans; Sundin, Johanna; Lubberink, Mark et al.

Part of British Journal of Haematology, p. 288-295, 1999

• DOI for Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography

Kinetics of 76Br-labeled anti-CEA antibodies in pigs: aspects of dosimetry and PET imaging properties

Lövqvist, Anna; Lundqvist, Hans; Lubberink, Mark; Tolmachev, Vladimir et al.

Part of Medical physics (Lancaster), p. 249-258, 1999

• DOI for Kinetics of 76Br-labeled anti-CEA antibodies in pigs: aspects of dosimetry and PET imaging properties

Positron emission tomography and radioimmunotargeting: general aspects

Lundqvist, Hans; Lubberink, Mark; Tolmachev, Vladimir; Lövqvist, Anna et al.

Part of Acta Oncologica, p. 335-341, 1999

Binding of tellurium to hepatocellular selenoproteins during incubationwith inorganic tellurite: consequences for the activity ofselenium-dependent glutathione peroxidase

Garberg, Per; Engman, Lars; Tolmachev, Vladimir; Lundqvist, Hans et al.

Part of International Journal of Biochemistry and Cell Biology, p. 291-301, 1999

• DOI for Binding of tellurium to hepatocellular selenoproteins during incubationwith inorganic tellurite: consequences for the activity ofselenium-dependent glutathione peroxidase

Effects of dextranation on the pharmacokinetics of short peptides: A PETstudy on mEGF

Zhao, Qinghai; Tolmachev, Vladimir; Carlsson, Jörgen; Lundqvist, Hans et al.

Part of Bioconjugate chemistry, p. 938-946, 1999

• DOI for Effects of dextranation on the pharmacokinetics of short peptides: A PETstudy on mEGF

Quantification aspects of patient studies with 52Fe in positron emission tomography

Lubberink, Mark; Tolmachev, Vladimir; Beshara, Soheir; Lundqvist, Hans

Part of Applied Radiation and Isotopes, p. 707-715, 1999

• DOI for Quantification aspects of patient studies with 52Fe in positron emission tomography

Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF

Zhao, QH; Tolmachev, V; Carlsson, J; Lundqvist, H et al.

Part of BIOCONJUGATE CHEMISTRY, p. 938-946, 1999

Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinicaltrials

Zhao, Q; Blomquist, E; Bolander, H; Gedda, Lars et al.

Part of International Journal of Molecular Medicine, p. 693-702, 1998

In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker

Bergström, Mats; Lu, Li; Fasth, Karl-Johan; Wu, Feng et al.

Part of Journal of Nuclear Medicine, p. 1273-9, 1998

Production of 76Br by a low-energy cyclotron

Tolmachev, Vladimir; Lövqvist, Anna; Einarsson, Lars; Schultz, Joachim et al.

Part of Applied Radiation and Isotopes, p. 1537-1540, 1998

Production of 61Cu from a natural nickel target

Tolmachev, Vladimir; Lundqvist, Hans; Einarsson, Leif

Part of Applied Radiation and Isotopes, p. 79-81, 1998

• DOI for Production of 61Cu from a natural nickel target

Positron Emission Tomography

Lundqvist, Hans; Lubberink, Mark; Tolmachev, Vladimir

Part of European journal of physics, p. 537-552, 1998

• DOI for Positron Emission Tomography

Production of Cu-61 from a natural nickel target

Tolmachev, V; Lundqvist, H; Einarsson, L

Part of APPLIED RADIATION AND ISOTOPES, p. 79-81, 1998

Production of Br-76 by a low-energy cyclotron

Tolmachev, V; Lovqvist, A; Einarsson, L; Schultz, J et al.

Part of APPLIED RADIATION AND ISOTOPES, p. 1537-1540, 1998

Labelling of boron containing compounds with halogen isotopes

Tolmachev, Vladimir; Lundqvist, Hans; Sivaev, Igor; Orlova, Anna et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 122, 1997

76-Br-bromodeoxyuridine marker with PET-preclinical validation studies

Fast, K J; Bergström, M; Hedberg, E; Cheng, A et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 391-393, 1997

• DOI for 76-Br-bromodeoxyuridine marker with PET-preclinical validation studies

Diffusion based separation methods: Dry distillation of zinc, cadmium and mercury isotopes from irradiated targets

Tolmachev, Vladimir; Lundqvist, Hans; Einarsson, Lars

Part of Applied Radiation and Isotopes, p. 565-569, 1997

• DOI for Diffusion based separation methods: Dry distillation of zinc, cadmium and mercury isotopes from irradiated targets

Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

Tolmachev, Vladimir; Lundqvist, Hans; Carlsson, Jörgen; Sivaev, Igor et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 125-127, 1997

• DOI for Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

Diffusion-based separation methods: Dry distillation of zinc, cadmium and mercury isotopes from irradiated targets

Tolmachev, V; Lundqvist, H; Einarsson, L

Part of APPLIED RADIATION AND ISOTOPES, p. 565-569, 1997

Rapid separation of gallium from zink targets by thermal diffusion

Tolmachev, Vladimir; Lundqvist, Hans

Part of Applied Radiation and Isotopes, p. 297-299, 1996

Rapid separation of gallium from zinc targets by thermal diffusion

Tolmachev, V; Lundqvist, H

Part of APPLIED RADIATION AND ISOTOPES, p. 297-299, 1996

Rapid separation of 110In from enriched Cd targets by thermal diffusion

Lundqvist, Hans; Tolmachev, Vladimir; Bruskin, Alexander; Einarsson, Lars et al.

Part of Applied Radiation and Isotopes, p. 859-863, 1995

A search for the optimal positron emitting label for DTPA-octreotide

Bruskin, Alexander; Lundqvist, Hans; Westlin, Jan-Erik; Arnberg, Håkan et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 506-509, 1995

Radio-bromination of anti-HER2/neu/erbB-2 monoclonal antibody using p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-).

Winberg, Karl Johan; Persson, Mikael; Tolmachev, Vladimir; Sjöberg, Stefan

Synthesis, radioiodination, DNA binding and cellular uptake of some doxorubicin analogues

Winander, Cecilia; Gedda, Lars; Tolmachev, Vladimir; Sjöberg, Stefan

Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy

Eissler, Nina; Altena, Renske; Alhuseinalkhudhur, Ali; Bragina, Olga et al.

Part of Biomedicines, 2024

• DOI for Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
• Download full text (pdf) of Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy

Targeted nuclear medicine. Seek and destroy

Tolmachev, Vladimir; Chernov, Vladimir I.; Deyev, Sergey M.

Part of Russian Chemical Reviews, 2022

• DOI for Targeted nuclear medicine. Seek and destroy

The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer

Bragina, Olga D.; Deyev, Sergei M.; Chernov, Vladimir; Tolmachev, Vladimir

Part of ACTA NATURAE, p. 4-15, 2022

• DOI for The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer
• Download full text (pdf) of The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

Rinne, Sara S.; Orlova, Anna; Tolmachev, Vladimir

Part of International Journal of Molecular Sciences, 2021

• DOI for PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
• Download full text (pdf) of PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer

Tolmachev, Vladimir; Orlova, Anna; Sörensen, Jens

Part of Seminars in Cancer Biology, p. 185-197, 2021

• DOI for The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer

Affibody Molecules as Targeting Vectors for PET Imaging

Tolmachev, Vladimir; Orlova, Anna

Part of Cancers, 2020

• DOI for Affibody Molecules as Targeting Vectors for PET Imaging
• Download full text (pdf) of Affibody Molecules as Targeting Vectors for PET Imaging

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer: Influence of Labeling Chemistry on Targeting Properties

Mitran, Bogdan; Tolmachev, Vladimir; Orlova, Anna

Part of Current Medicinal Chemistry, p. 7090-7111, 2020

• DOI for Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer: Influence of Labeling Chemistry on Targeting Properties

Basic and practical concepts of radiopharmaceutical purification methods

Molavipordanjani, Sajjad; Tolmachev, Vladimir; Hosseinimehr, Seyed Jalal

Part of Drug Discovery Today, p. 315-324, 2019

• DOI for Basic and practical concepts of radiopharmaceutical purification methods

Radiolabelled proteins for positron emission tomography: pros and cons of labelling methods

Tolmachev, Vladimir; Stone-Elander, Sharon

Part of Biochimica et Biophysica Acta, p. 487-510, 2010

• DOI for Radiolabelled proteins for positron emission tomography: pros and cons of labelling methods

Radionuclide molecular imaging using affibody molecules

Ahlgren, Sara; Tolmachev, Vladimir

Part of Current Pharmaceutical Biotechnology, p. 581-589, 2010

• DOI for Radionuclide molecular imaging using affibody molecules

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

Tolmachev, Vladimir; Stone-Elander, Sharon; Orlova, Anna

Part of The Lancet Oncology, p. 992-1000, 2010

• DOI for Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications

Löfblom, John; Feldwisch, Joachim; Tolmachev, Vladimir; Carlsson, Jörgen et al.

Part of FEBS Letters, p. 2670-2680, 2010

• DOI for Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications

Imaging of HER-2 overexpression in tumors for guiding therapy

Tolmachev, Vladimir

Part of Current pharmaceutical design, p. 2999-3019, 2008

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

Tolmachev, Vladimir; Orlova, Anna; Nilsson, Fredrik Y.; Feldwisch, Joachim et al.

Part of Expert Opinion on Biological Therapy, p. 555-568, 2007

• DOI for Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy

Nilsson, Fredrik Y.; Tolmachev, Vladimir

Part of Current opinion in drug discovery & development, p. 167-175, 2007

Preparation of Conjugates for Affibody-Based PNA-Mediated Pretargeting

Altai, Mohamed; Vorobyeva, Anzhelika; Tolmachev, Vladimir M.; Karlström, Amelie Eriksson et al.

Part of Peptide Nucleic Acids, p. 283-304, Springer Nature, 2020

• DOI for Preparation of Conjugates for Affibody-Based PNA-Mediated Pretargeting

Methods for radiolabelling of monoclonal antibodies

Tolmachev, Vladimir; Orlova, Anna; Andersson, Karl

Part of Human Monoclonal Antibodies, p. 309-330, Humana Press, 2014

• DOI for Methods for radiolabelling of monoclonal antibodies
• Download full text (pdf) of Methods for radiolabelling of monoclonal antibodies

Radiohalogenated Polyhedral Borate Anaions for use in Targeted Oncological Radionuclide Therapy, Some Recent Developments

Tolmachev, V.; Bruskin, A.; Orlova, A.; Winberg, K.J. et al.

Part of Boron Chemistry at the Beginning of the 21st Century. Y.N Bubnov, p. 338-3342, Editoral URSS, Scientific Literature and Textbooks,, Moscow, 2003

Effect of ionizing radiation on the labeling of closo-dodecaborate(2-) anion with 125I

Lebeda, Ondrej; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

Part of Contemporary Boron Chemistry, Royal Society of Medicine Press, 2000

• DOI for Effect of ionizing radiation on the labeling of closo-dodecaborate(2-) anion with 125I

Closo-dodecaborate (2-) anion as a prosthetic group for labelling proteins with a astatine

Orlova, Anna; Lebeda, O.; Tolmachev, Vladimir; Sjöberg, S. et al.

Part of Contemporary Boron Chemistry, p. 144-147, Royal Society of Chemistry, 2000

Effect of ionising radiation on the labelling of closo-dodecaborate (2-) anion

Lebeda, Ondrej; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

Part of Contemporary Boron Chemistry, p. 148-154, Royal Society of Chemistry, 2000

Synthesis and Preclinical Evaluation of GRPR Antagonist [¹⁸F]-MeTz-PEG₂-RM26 for Position Emission Tomography

Lundmark, Fanny; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Tolmachev, Vladimir et al.

Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)

Orlova, Anna; Bruskin, Alexander; Sivaev, Igor; Sjöberg, Stefan et al.

Part of Anticancer Research, p. 1217-1223, 2006

[111In]-DTPA-hEGF and [111In]-Bz-DTPA-hEGF: preparation and in vitro studies of two anti- glioblastoma conjugates with residualising labels

Liljegren Sundberg, Åsa; Orlova, Anna; Bruskin, Alexander; Gedda, Lars et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 354-354, 2002

Cellular processing of iodinated and astatinated trastuzumab in cultured SK-BR-3 breast cancer cells

Persson, Mikael; Orlova, Anna; Gedda, Lars; Carlsson, Jörgen et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 353-354, 2002

Pharmacokinetics in tumour-bearing rats of directly and indirectly 76Br-brominated MAb A33: Comparison with 125I-iodinated counterparts

Höglund, Johanna; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

2002

Cellular processing of indirectly astatinated and iodinated mAb A33 in SW1222 cultured cells

Orlova, Anna; Sjöström, Anna; Ericson, A.; Lebeda, Ondrej et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2001

• DOI for Cellular processing of indirectly astatinated and iodinated mAb A33 in SW1222 cultured cells

Synthesis of [211At] N-[8-(acridin-9-ylamino)-octyl]-3- astatobenzamide, an astatinated DNA intercalator

Orlova, Anna; Bohl, E.; Ghaneolhosseino, H.; Gedda, Lars et al.

Part of European Journal of Nuclear Medicine, p. 317, 2000

Cellular processing of ¹²⁵I- and ¹¹¹in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells

Orlova, Anna; Bruskin, Alexander; Sjöström, Anna; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 827-835, 2000

• DOI for Cellular processing of ¹²⁵I- and ¹¹¹in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells

Indium-octreotide: labels for PET and therapy

Tolmachev, Vladimir; Lubberink, Mark; Bernhardt, P.; Forsell-Aronsson, E. et al.

Part of Nuclear medicine communications, p. 580-581, 2000

PET and dosimetry

Lundqvist, Hans; Tolmachev, Vladimir; Bruskin, Alexander

Part of Abstracts of 4th Scandinavian Symposium on Radiolabeled Monoclonal Antibodies in Diagnosis and Therapy of Cancer. January 15-17, 1995, Lillehammer, Norway, p. 28, 1995